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Gender, Race & the Inadequate
Regulation of Cosmetics
Marie Boyd(
ABSTRACT: Scholars and other commentators have identified failures in the
regulation of cosmeticsFwhich depends heavily on voluntary industry self-
regulationFand called for more stringent regulation of these products. Yet these
calls have largely neglected an important dimension of the problem: the current
laissez-faire approach to the regulation of cosmetics disproportionally places
women, and particularly women who are members of other excluded groups, at
risk. This Article examines federal cosmetics law and regulation through a
feminist lens. It argues that cosmetics law and regulation have lagged behind that
of the other major product categories regulated by the Food and Drug
Administration under the Federal Food, Drug, and Cosmetic Act of 1938 because
cosmetics are a gendered product and industry. In addition, conflicting views of
the meaning of cosmetics among self-identified feminists, and differences in
Z,.en’s relati,nsCi*s t, H,s.etiHs, mean that reform efforts must confront
opposition and tension both within and outside of feminism. Ultimately, this
Article questions the legitimacy of the current approach to cosmetics law and
regulation. It concludes with several recommendations about how to address
some of the failures of cosmetics law and regulation.
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INTRODUCTION
The e)cessive use of lipstick has greatly increased the world’s troubles.
Lipstick is not healthful for women. It is not safe for men.1
The approximately fifty billion-dollar American cosmetics and beauty
product industry is a gendered industry,2 DHreated and .aintained bW Z,.en.33
/CetCer tCis industrW Dis a Car.fulS ,bBeHtifWing Hreati,n ,r a s,urHe ,f strengtC
and inde*endenHe f,r Z,.en3 Cas been desHribed as D,ne ,f tCe .,st
H,ntenti,us debates in #.eriHan fe.inis.s.34 Regardless of whether cosmetics
are viewed as oppressive, liberating, or something else, many women use or are
otherwise exposed to cosmetics.5 For example, 86 percent ,f Z,.en Duse s,.e
1. CHARLES WESLEY DUNN, FEDERAL FOOD, DRUG, AND COSMETIC ACT: A STATEMENT OF ITS
LEGISLATIVE RECORD 156 (1938) (reproducing 78 Cong. Rec. 8955-67 (May 16, 1934)) (statement of
Senator Matthew Mansfield Neely during debate on legislation to extend federal food and drug law to
cosmetics, which ultimately culminated in the passage of the Federal Food, Drug, and Cosmetic Act
(FDCA) of 1938).
2. See ANYA COHEN, IBISWORLD INDUSTRY REPORT 32562: COSMETIC & BEAUTY PRODUCTS
MANUFACTURING IN THEUS 4 (Mar. 2018). The Dcosmetic and beauty product industry3 definition is not
entirely coterminous with the FDCA’s definition of Dcosmetics.3 Compare id. at 2, with FDCA § 201(i),
21 U.S.C. § 321(i) (2012); see also infra Section I.A (discussing the FDCA’s definition of cosmetics).
3. Amber R. Clifford, Feminism, in THE AMERICAN BEAUTY INDUSTRY ENCYCLOPEDIA 111 (Julie
Willett ed., 2010) (stating that Dthe key to the growth of the American beauty industry has been the
involvement of women as consumers, creators, and icons3). Of course, men also use cosmetics and men’s
personal care products are a growing industry. See RITA FREEDMAN, BEAUTYBOUND 225 (1986) (stating
that men Dare buying more cosmetics every year3); GWEN KAY, DYING TO BE BEAUTIFUL: THE FIGHT
FOR SAFE COSMETICS (2005); KATHY PEISS, HOPE IN A JAR: THE MAKING OF AMERICA’S BEAUTY
CULTURE (1998); Andria Cheng, The Surprising Trend in Beauty? Skincare Sales Growing the Fastest
Among Men’s Grooming Products, FORBES (June 15, 2018, 6:00 AM), https://www.forbes.com/
sites/andriacheng/2018/06/15/the-gift-your-dad-really-wants-this-fathers-day-anti-aging-cream/#71241e
5133ba [https://perma.cc/3DVZ-58XU]; MINTEL, MEN’S PERSONAL CARE U.S. (Nov. 2017) [hereinafter
MEN’S PERSONAL CARE].
4. Clifford, supra note 3, at 111; see, e.g., FREEDMAN, supra note 3, at 53, 231 (DCosmetic strategies
do help to normalize women, but they insidiously confirm female deviance even while counterbalancing
it.3); id. at 231 (DIf women don’t want to be regarded as decorative dolls, can they still delight in self-
display? Is the ultimate goal to be accepted for oneselfFuncoiffed, unadorned, and therefore, in the eyes
of many, unkempt? . . . When are cosmetic transformations a negative act of self-rejection, and when are
they a positive act of self-enhancement? . . . Many feminists have difficulty finding personal answers to
such questions, for they, too, experience the conflict between conviction and convention, between the
utopian ideal of natural beauty that includes all, and the actual ideal of cultured beauty that excludes so
many.3); NAOMIWOLF, THEBEAUTYMYTH: HOW IMAGES OFBEAUTYAREUSED AGAINSTWOMEN 113
(1992) (discussing the cosmetics industry and stating that D[w]asting women’s money is the calculable
damage; but the damage this fraud does women through its legacy of the dread of aging is incalculable3);
BELL HOOKS, BLACK LOOKS: RACE AND REPRESENTATION (1992).
5. This exposure may not be voluntary. For example, employers may have dress codes that require
female employees to wear makeup. See Jespersen v. Harrah’s Operating Co., 444 F.3d 1104 (9th Cir.
2006). Many women are exposed to cosmetics in their workplaces. For example, according to industry
estimates, 96% of the workforce in nail salons and other personal care services in the United States is
women. CENTERS FORDISEASECONTROL&PREVENTION, NAT’L INST. FOROCCUPATIONALSAFETYAND
HEALTH (NIOSH), NAILTECHNICIANS’HEALTHANDWORKPLACEEXPOSURECONTROL (internal citation
omitted), https://www.cdc.gov/niosh/topics/manicure/default.html [https://perma.cc/F7AH-H94U] [here-
inafter NIOSH, NAILTECHNICIANS’HEALTH]. There is also debate over whether or not cosmetics use can
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type of make-u*3 and Z,.en H,.*rise 8?.; percent of hairdressers, hairstylists,
and cosmetologistsFjobs that often involve exposure to cosmetics.6
TCe P,,d and _rug #d.inistrati,n UP_#T regulates DH,s.etiHs3 under tCe
Federal Food, Drug, and Cosmetic Act (FDCA). Since enacting the FDCA in
@8>9S !,ngress Cas signifiHantlW HCanged and strengtCened tCe #Ht’s *r,'isi,ns
for the other major product categories that were present in the original 1938 Act
(i.e., food, drugs, and medical devices). However, the cosmetics provisionsF
which span less than two pages of the approximately 500-page amended
FDCAFhave remained largely unchanged for the past eighty years.7
Accordingly, there is a substantial divide between the law and regulation for
cosmetics and that for the other major product categories.8 Cosmetics are the
least regulated ,f tCe .aB,r *r,duHt Hateg,ries ZitCin P_#’s BurisdiHti,n.9 The
_ireHt,r ,f P_#’s 7ffiHe ,f !,s.etiHs and !,l,rs Cas statedS f,r eXa.*leS tCat
P_# d,es n,t DAn,Z tCe nu.ber ,f .anufaHturers \,f tatt,, inAs Ua tW*e ,f
H,s.etiHT[S ZC, tCeW areS ZCere tCeW areS and ZCat tCeW .aAe.310 The Director
has also indicated that P_# is DBust seeing tCe ti* ,f tCe iHeberg3 in ter.s ,f tCe
reporting of adverse events related to cosmetics in the voluntary reporting
system.11
TCe H,s.etiHs industrW Cas argued tCat D\H[,s.etiHs are tCe safest *r,duHts
tCat P_# regulates.312 Yet this does not mean that cosmetics are safe, given the
ever be truly voluntary given societal pressures. See, e.g., FREEDMAN, supra note 3, at 48 (discussing
beauty routines and the Dstrong human need to conform to social norms3); PEISS, supra note 3, at 4.
6. MINTEL, COLORCOSMETICS-US-JULY 2017 [hereinafter COLORCOSMETICS]; BUREAUOFLABOR
STATISTICS, EMPLOYED PERSONS BY DETAILED OCCUPATION, SEX, RACE, AND HISPANIC OR LATINO
ETHNICITY tbl.11 (Jan. 19, 2018), https://www.bls.gov/cps/cpsaat11.htm [https://perma.cc/Y5PW-TP7R]
[hereinafter BLS, DETAILEDOCCUPATION] (DHairdressers, hairstylists, and cosmetologists3).
7. See FDCA, 21 U.S.C. ch. 9 (2012); compare FDCA, 21 U.S.C. §§ 361-364 (1938 supp. IV) with
FDCA, 21 U.S.C. §§ 361-364 (2012); see also 21 U.S.C.A. §§ 361-364 (West 2018).
8. See infra Section II.C.2.e. (discussing how cosmetics law and regulation lag behind that of other
product categories.)
9. Jordan Paradise & Ethan Fitzpatrick, Synthetic Biology: Does Re-Writing Nature Require Re-
Writing Regulation?, 117 PENN ST. L. REV. 53, 70 (2012); see also U.S. GEN. ACCOUNTING OFFICE
(GAO), GAO/HRD-90-58, COSMETICS REGULATION: INFORMATION ON VOLUNTARY ACTIONS AGREED
TO BY FDA AND THE INDUSTRY (Mar. 1990), https://www.gao.gov/assets/220/212263.pdf [https://perma.
cc/JH3V-CF3X] [hereinafter GAO/HRD-90-58]; U.S. GEN. ACCOUNTING OFFICE (GAO), STATEMENT
OFGREGORY J. AHART, DIRECTOR, HUMANRESOURCESDIV., BEFORE THE SUBCOMM. ONOVERSIGHT&
INVESTIGATIONS, HOUSE COMM. ON INTERSTATE AND FOREIGN COMMERCE ON THE FOOD AND DRUG
ADMINISTRATION’S REGULATION OF COSMETICS (Feb. 3, 1978), https://www.gao.gov/assets/100/98639.
pdf [https://perma.cc/QEF8-XKSP]; U.S. GEN. ACCOUNTING OFFICE (GAO), HRD-78-139, LACK OF
AUTHORITYHAMPERSATTEMPTS TO INCREASECOSMETIC SAFETY (Aug. 8, 1978), https://www.gao.gov/
assets/130/123795.pdf [https://perma.cc/7VD6-MV6Y] [hereinafter GAO, HRD-78-139].
10. FDA,Using Adverse Event Reports to Monitor Cosmetic Safety: A Conversation with Linda Katz
(Nov. 3, 2017), https://www.fda.gov/cosmetics/complianceenforcement/adverseeventreporting/ucm531
634.htm [https://perma.cc/U7AH-H8TA] [hereinafter FDA, Adverse Event Reports].
11. FDA, Adverse Event Reports, supra note 10.
12. See, e.g., Testimony Peter Barton Hutt, Senior Counsel, Covington & Burling, LLP, Before the
Health Subcomm. of Comm. on Energy & Commerce U.S. House of Representatives (Mar. 27, 2012),
https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearing
s/Health/20120327/HHRG-112-IF14-WState-HuttP-20120327.pdf [https://perma.cc/MU6J-STYJ]; Test-
imony of Halyna Breslawec, Ph.D., Chief Scientist & Exec. Vice President for Sci., Pers. Care Prod.
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large number of people that foodborne illnesses, medications, and tobacco
products kill and injure each year.13 Indeed, there is much uncertainty about the
safety of cosmetics, and some may not be safe.14 Yet the current approach to
cosmetics law and regulation, rather than helping to assess these claims, hinders
meaningful evaluation of the safety of the industry.
This Article examines federal cosmetics law and regulation from a feminist
perspective.15 SpecificallyS it asAs tCe DZ,.an )uesti,n3 ab,ut H,s.etiHs laZ
and regulati,n in ,rder t, DidentifW tCe gender i.*liHati,ns3 ,f tCis regulat,rW
sWste.S DZCiHC .igCt ,tCerZise a**ear t, be neutral ,r ,bBeHti'e.316 The
association between cosmetics and femininity is so strong that some readers may
)uesti,n ZCetCer tCere is e'en a need t, asA tCe DZ,.an )uesti,n3 ab,ut
cosmetics law and regulation. But as this Article argues, the relationship between
the under-regulation of cosmetics and their association with women is both
strong and complex. Cosmetics law and regulation have been deprioritized for
.anW reas,nsS inHluding as a result ,f differenHes in Z,.en’s usage ,f
cosmetics, the longstanding and close association of cosmetics with femininity
and women, and the debate among self-described feminists regarding cosmetics.
Explicitly considering how cosmetics law and regulation fail to account for the
needs and experiences of women and members of other excluded groups is
necessary if these omissions are to be remedied.
Council, Before the Health Subcomm. of Comm. on Energy & Commerce U.S. House of Representatives
(Mar. 27, 2012), https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.
gov/files/Hearings/Health/20120327/HHRG-112-IF14-WState-BreslawecH-20120327.pdf [https://perm
a.cc/PDS4-Q7YD].
13. There are an estimated D106 000 deaths/year from nonerror, adverse effects of medications3 in
the United States. Barbara Starfield, Commentary, Is US Health Really the Best in the World?, 284 JAMA
483, 484 (July 26, 2000). In addition, the Centers for Disease Control and Prevention estimates that
D[a]bout 48 million people (1 in 6 Americans) get sick, 128,000 are hospitalized, and 3,000 die each year
from foodborne diseases.3 FDA, FOOD SAFETY MODERNIZATION ACT (FSMA), INSPECTION &
COMPLIANCE, https://www.fda.gov/food/guidanceregulation/fsma/ucm257978.htm [https://perma.cc/3E
FM-LMAW]. About D16 million Americans are living with a disease caused by smoking3 and Dcigarette
smoking is responsible for more than 480,000 deaths per year in the United States.3 Centers for Disease
Control & Prevention, Fast Facts: Diseases and Death, https://www.cdc.gov/tobacco/data_statistics/
fact_sheets/fast_facts/index.htm [https://perma.cc/A2AA-4JVC].
14. See also infra Section II.B (discussing potential risks and harms of cosmetics).
15. This Article focuses on gender and FDA’s regulation of cosmetics with respect to human health
and safety under the FDCA; it does not consider the role that other federal laws (e.g., the Toxic Substances
Control Act, the Federal Trade Commission Act, Occupational Safety & Health Act) and agencies (e.g.,
EPA, FTC, and OSHA) play in the regulation of cosmetics. See, e.g., FED. TRADE COMM’N (FTC),
https://www.ftc.gov/ [https://perma.cc/588Y-M9AN]; U.S. ENVTL. PROT. AGENCY (EPA), https://www.
epa.gov/ [https://perma.cc/32WU-2U3N]; U.S. DEP’T OF LABOR OCCUPATIONAL SAFETY & HEALTH
ADMIN. (OSHA), https://www.osha.gov/ [https://perma.cc/SLJ7-37NY]; Occupational Safety & Health
Act, Pub. L. No. 91-956, 84 Stat. 1590 (codified as amended at 29 U.S.C. §§ 651-78 (2012)); Federal
Trade Commission Act, 15 U.S.C. §§ 41-58 (2018 supp. V); Lanham Act, 15 U.S.C. § 1125(a) (2012);
Toxic Substances Control Act, 15 U.S.C. § 2604 (2018 supp. V). This Article also does not examine state
cosmetics laws and tort law. See, e.g., California Safe Cosmetics Act, http://www.leginfo.ca.gov/pub/05-
06/bill/sen/sb_0451-0500/sb_484_bill_20051007_chaptered.pdf [https://perma.cc/B75T-9C3X]; 148
AM. JUR. 3D Proof of Facts § 207 (originally published in 2015).
16. See Katharine T. Bartlett, Feminist Legal Methods, 103 HARV. L. REV. 829, 837 (1990).
280 Yale Journal of Law and Feminism [Vol. 30:2
This Article proceeds as follows: Part I defines several key terms and
intr,duHes tCe DZ,.an )uesti,n3 as a fe.inist legal .etC,d. 6art II eXa.ines
cosmetics as a gendered product and industry, and highlights several ways that
product use and exposure may be shaped by the intersection of gender, race, and
class. It then discusses the safety of cosmetics and explains why women, and
particularly women who are members of other excluded groups, may be
disproportionately impacted by the failures of cosmetics law and regulation. Part
II then provides an overview of cosmetics law and regulation, with a focus on
how they have lagged behind that of the other major product categories in the
FDCA. Against this backdrop, Part III argues that cosmetics law and regulation
have been deprioritized as a result of their longstanding and close association
ZitC fe.ininitW and Z,.enS as Zell as Z,.en’s eXHlusi,n fr,. *,litiHal
participation and representation. It also argues that cosmetics law and regulation
have been deprioritized as a result of the debate among self-described feminists
,'er tCe .eaning ,f H,s.etiHsS as Zell as differenHes in Z,.en’s relati,nsCi*s
to and perspectives on cosmetics. Part IV considers the implications of this
analysis for reform. Ultimately, this Article uses a feminist lens to question the
legitimacy of the current approach to cosmetics law and regulation and strives to
make readers do the same.17
I. TERMINOLOGY&METHODOLOGY
Before turning to a discussion of the gendered and racialized impact of the
contemporary regulation of cosmetics in Part II, the current Part discusses
several important terms and provides a discussion of the method employed in
later seHti,ns. In *artiHularS tCis #rtiHle uses an eX*anded 'ersi,n ,f DtCe Z,.an
)uesti,nS3 ZCiHC analWVes Dgender . . . ZitCin tCe H,nteXts ,f.ulti*le identities3
t, asA C,Z H,s.etiHs laZ and regulati,n Dlea'e ,ut ,r disad'antage Z,.en and
.e.bers ,f ,tCer eXHluded gr,u*s.318
A. Defining “Cosmetics”
TCis #rtiHle f,Huses ,n DH,s.etiHs3 as defined under tCe P_!A. The FDCA
defines DH,s.etiHs3 t, .ean DartiHles intended t, be rubbedS *,uredS s*rinAledS
or sprayed on, introduced into, or otherwise applied to the human body or any
part thereof for cleansing, beautifying, promoting attractiveness, or altering the
17. See Allison M. Blackman,Manufactured Home Displacement and Its Disparate Impact on Low-
Income Females: A Violation of the Fair Housing Act in Boise, Idaho?, 4 THE CRIT: CRITICAL STUD. J.
67, 68-69 (2011) (DThus, the underlying goal of this article is to challenge and provokeFto raise
awareness about involuntary manufactured home displacement, and ultimately to make readers question
the legitimacy of 2fair housing’ laws in their status quo operation.3).
18. Bartlett, supra note 16, at 831, 848.
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appearanHe.319 The definition includes components of such articles but excludes
soap, which FDA has defined narrowly.20 For example, cosmetics include hair
products (e.g., hair dyes, permanent waves, relaxers, cleansing shampoos, and
conditioners), makeup (e.g., eye products, lipstick, novelty makeup, permanent
makeup, and tattoo ink), nail products (e.g., fingernail polishes and artificial
nails), perfumes, deodorants, and skin moisturizers.21
Because the subject of this Article is cosmetics law and regulation, this
Article focuses on products that FDA regulates as cosmetics, not as cosmetics
and another product category (i.e., products with dual classification).22 It is
i.*,rtant t, n,teS C,Ze'erS tCat DH,s.etiHs3 .aW als, .eet tCe definiti,n ,f ,ne
,f tCe P_!#’s ,tCer *r,duHt Hateg,ries. P,r eXa.*leS a DH,s.etiH3 .aW als, be
a DdrugS323 ZCiHC inHludes artiHles intended f,r tCera*eutiH use and DartiHles . . .
intended t, affeHt tCe struHture ,r anW funHti,n ,f tCe b,dW ,f .an.324 The
intended use of a product is central to determining whether it is a cosmetic or a
drug or both.25 TCe HlassifiHati,n ,f a *r,duHt deter.ines tCe sH,*e ,f P_#’s
authority over it and the requirements that the manufacturer must meet. If a
product is a drug or a drug and a cosmetic, it is subject to the requirements for
19. FDCA § 201(i), 21 U.S.C. § 321(i) (2012).
20. Id. The FDA has interpreted the term Dsoap3 to mean articles where D[t]he bulk of the nonvolatile
matter . . . consists of an alkali salt of fatty acid and the detergent properties . . . are due to the alkali-fatty
acid compounds3 and articles that are Dlabeled, sold, and represented only as soap.3 21 C.F.R. § 701.20
(2018).
21. FDA, FDA AUTHORITY OVER COSMETICS: HOW COSMETICS ARE NOT FDA-APPROVED, BUT
ARE FDA-REGULATED, https://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm074
162.htm [https://perma.cc/G8NJ-9S5A] [hereinafter FDAAUTHORITYOVER COSMETICS].
22. Cosmetics may include ingredients that are regulated as Dcolor additives,3 however, these are
distinct regulatory categories with distinct regulatory requirements. See FDCA § 201(t), 21 U.S.C.
§ 321(t) (2012) (Dcolor additive3); FDCA § 301(i), 21 U.S.C. § 321(i) (2012) (Dcosmetic3); FDCA § 721,
21 U.S.C. § 379e (2012) (Listing and Certification of Color Additives for Foods, Drugs, Devices, and
Cosmetics). Unlike Dcosmetics,3 Dcolor additives3 have to be listed (i.e., approved) for a particular use
before being so used. Id. Perhaps most importantly for the purposes of the current analysis, Dcolor
additives3 are not limited to use in cosmetics. Id. FDA may approve a color additive for use in or on food,
drugs, and devicesFproduct categories that unlike cosmetics do not have a long gendered-history. See
infra Section II.A.
23. See 21 U.S.C. § 359 (stating that the drugs and devices subchapter of FDCA Dshall not apply to
any cosmetic unless such cosmetic is also a drug or device3); see also FDA, IS IT A COSMETIC, A DRUG,
OR BOTH? (OR IS IT SOAP?), https://www.fda.gov/cosmetics/guidanceregulation/lawsregulations/ucm
074201.htm [https://perma.cc/U3X4-2N3A].
24. FDCA § 201(g)(1), 21 U.S.C. § 321(g)(1) (2012).
25. See FDCA § 201(g), (i), 21 U.S.C. § 321(g), (i) (2012); see also Laura A. Heymann, The
Cosmetic/Drug Dilemma: FDA Regulation of Alpha-Hydroxy Acids, 52 FOOD & DRUG L.J. 357, 358
(1997) (stating that the answer to the question of whether a product is a cosmetic or a drug under most
interpretations of the FDCA is Drooted not in the chemical composition or physiological effect of AHAs
but rather in how the manufacturer has positioned the product and the promises made as to its effects3).
But see PETER BARTONHUTT ET AL., FOOD ANDDRUG LAW: CASES ANDMATERIALS 118 (4th ed. 2014)
(DFDA has manifested an inclination to categorize articles containing pharmacologically active
ingredients as drugs even when their manufacturers make only cosmetic claims.3). The cosmetics industry
uses the term cosmeceutical to Drefer to cosmetic products that have medicinal or drug-like benefits,3 but
neither FDCA nor FDA recognize this term. FDA, COSMECEUTICAL, https://www.fda.gov/cosmetics/
labeling/claims/ucm127064.htm [https://perma.cc/RHV7-X36X].
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drugs, which are much more stringent than those for cosmetics.26 For example,
P_# .ust a**r,'e a DneZ drug3 bef,re it Han be laZfullW s,ldS27 whereas no
approval is needed for a cosmetic.28
Because cosmetics law and regulation lag so far behind the law and
regulation of the other major product categories, there is a lot riding on a
*r,duHt’s HlassifiHati,n and it is a signifiHant s,urHe ,f tensi,n: indeedS ,ne
commentator wrote tCat tCis tensi,n DCas been tCe *ri.arW feature ,f tCe
e',luti,n ,f H,s.etiH laZ in tCe last fiftW Wears.329
Finally, because some of the literature and sources cited in this Article use
terms such as personal care products, beauty products, beauty supplies, and toilet
preparations, it is important to note that while these terms may include
DH,s.etiHsS3 tCeW are n,t H,ter.in,us ZitC tCe legal definiti,n ,f H,s.etiHs. For
example, these terms may include products that fall within another product
category under the FDCA (e.g., drugs, devices, or dietary supplements) or
outside of its reach entirely (e.g., consumer products).30
B. The “Woman #uestion” as a Feminist Legal Method
This Section begins bW defining fe.inis.. It tCen disHusses tCe DZ,.an
)uesti,n3 as a fe.inist legal .etC,dFincluding tCe .etC,d’s strengths and
limitationsFand how this Article employs the method to examine federal
cosmetics law and regulation.31
26. See infra Section II.C.2.e.
27. FDCA §§ 201, 505(a), 21 U.S.C. §§ 321, 355(a) (2012); see also Jacqueline A. Greff, Regulation
of Cosmetics That Are Also Drugs, 51 FOOD&DRUG L.J. 243 (1996); Heymann, supra note 25, 364. The
new drug development and application process is time-consuming and expensive: it can take over a decade
and hundreds of millions of dollars. See Gail A. Van Norman, Drugs, Devices and the FDA: Part 1: An
Overview of Approval Processes for Drugs, 1 JACC: BASIC TO TRANSLATIONAL SCI. 170 (Apr. 2016),
https://www.sciencedirect.com/science/article/pii/S2452302X1600036X [https://perma.cc/PCT8-X9WT
]; Joseph A. DiMasi et al., Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs, 47
J. HEALTH ECON. 20 (May 2016), https://www.sciencedirect.com/science/article/abs/pii/S0167629616
000291 [https://perma.cc/VN6E-Z3J6] (estimating the research and development costs (including post-
approval research and development) for a new drug to be about $2.87 billion dollars); Vinay Prasad &
Sham Mailankody, Research and Development Spending to Bring a Single Cancer Drug to Market and
Revenues After Approval, JAMA INTERNAL MED. 1569 (2017) https://jamanetwork.com/journals/
jamainternalmedicine/article-abstract/2653012 [https://perma.cc/6PH3-5KLH] (estimating research and
development costs to be about $648 million).
28. See FDCA, 21 U.S.C. ch. 9 (2012).
29. Greff, supra note 27, at 243.
30. See FDA, Cosmetics Safety Q&A: Personal Care Products, https://www.fda.gov/Cosmetics/
ResourcesForYou/Consumers/ucm136560.htm [https://perma.cc/JBU2-RUGQ]; FDA, Cosmetics &
Pregnancy, https://www.fda.gov/cosmetics/resourcesforyou/consumers/ucm388727.htm [https://perma.
cc/Y65D-KAQR] (last updated Mar. 6, 2018) (DNot all 2personal care products’ . . . are cosmetics.3).
31. See Bartlett, supra note 16.
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Defining Feminism
TCe ter. Dfe.inis.3 is Dtr,ubles,.e3: it is DH,nfusing and diffiHult3 and
e'en tCe n,ti,n ,f D2defining’ fe.inis. is H,ntr,'ersial.332 It has been defined
both narrowly and broadly, and is not static.33 Despite the many definitions of
feminism, feminism does have boundaries.34 It DtaAes gender as a Hentral
Hateg,rW ,f analWsis.335 One definition of fe.inis. is DtCe .,'e.ent f,r social,
*,litiHalS and eH,n,.iH e)ualitW ,f .en and Z,.en.336 Feminism according to
this definition consists of a movement with goals for changeS D\a[nd i.*liHit in
these goals is access to sufficient information to enable women to make
res*,nsible HC,iHes.337 Although having the benefits of being concise, this
definiti,n is n,t un*r,ble.atiHS as liAe ,tCer sC,rt definiti,ns it DreduHe\s] the
subtle complexity of a messy field of knowledge t, \a[ neat sl,gan\[.338
In her article, Feminist Critical Theories, Deborah L. Rhode identifies
several common features of the critical feminist theories that she examines.39
S*eHifiHallWS sCe states tCat U@T DtCeW seek to promote equality between women
and .en%3 U?T tCeW D.aAe gender a f,Hus ,f analWsis3 and Dai. . . . to
reconstitute legal practices that have excluded, devalued, or undermined
Z,.en’s H,nHerns%3 and U>T tCeW Das*ire t, desHribe tCe Z,rld in ZaWs tCat
H,rres*,nd t, Z,.en’s eX*erienHe and tCat identify the fundamental social
transformations necessary for full equality between the sexes.340 While the
approach of feminist theory differs from other critical approaches, like critical
legal studies and critical race scholarship, it also overlaps and often draws upon
these approaches.41 TCe general g,al ,f tCese tCe,riesS Dt, HCallenge eXisting
distributi,ns ,f *,ZerS3 is ,ne ZCiHC tCis #rtiHle sCares.42
32. CHRIS BEASLEY, WHAT IS FEMINISM? AN INTRODUCTION TO FEMINIST THEORY ix, xi (1999).
33. Id. at xiv, xiii, 25-48.
34. Id. at xv.
35. Deborah L. Rhode, Feminist Critical Theories, 42 STAN. L. REV. 617, 617-18 (1990); see also
Mary Anne C. Case, Disaggregating Gender from Sex and Sexual Orientation: The Effeminate Man in
the Law and Feminist Jurisprudence, 105 YALE L.J. 1, 6 (1995) (discussing Dhow gender and sex came
to be conflated in the language of the law3 and arguing that Dit is important to distinguish between them3);
Megan Bell, Comment, Transsexuals and the Law, 98 NW. U. L. REV. 1709, 1716 (2004) (discussing
distinctions between gender and sex).
36. JENNIFER BAUMGARDNER & AMY RICHARDS, MANIFESTA: YOUNG WOMEN, FEMINISM, AND
THE FUTURE 56 (2000).
37. Id.
38. See BEASLEY, supra note 32, at 26 (noting that despite the benefits of short definitions of
feminism, such definitions Dare of limited value if you want to grasp the character of the term, feminism,
more fully and appreciate its heterogenous forms3).
39. Rhode, Feminist Critical Theories, supra note 35.
40. Id. at 619.
41. Id. at 618G19.
42. Id.
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Asking the “Woman #uestion”
In Feminist Legal MethodsS KatCarine T. "artlett desHribes tCe DZ,.an
)uesti,n3 as a set ,f )uesti,ns Ddesigned t, identifW tCe gender i.*liHati,ns ,f
rules and *raHtiHes ZCiHC .igCt ,tCerZise a**ear t, be neutral ,r ,bBeHti'e.343
SCe *Crases tCese )uesti,ns as: D\N[a'e Z,.en been left ,ut ,f H,nsiderati,n$
If so, in what way; howmight that omission be corrected?What difference would
it .aAe t, d, s,$344 TCis in)uirW DCel*s t, de.,nstrate C,Z s,Hial struHtures
embody norms that implicitly render women different and thereby
sub,rdinate.345
TCe DZ,.an )uesti,n3 Cas been used t, DeXa.in\e[ C,Z tCe laZ fails t, taAe
into account the experiences and values that seem more typical of women than
of men . . . or how existing legal standards and concepts might disadvantage
Z,.en.346 There is a long history of feminist scholarship asking tCe DZ,.an
)uesti,n3 ab,ut di'erse areas ,f tCe laZ.47 For example, it has been asked in
some form about voting limitations, legal inequities associated with marriage,
and birth control.48 It Cas als, been asAed ab,ut tCe 4estate.ent UTCirdT’s
standard for medical product defect claims,49 pharmacist refusal clauses,50 health
care reform,51 and how the legal system has responded to HIV infection.52
This Article adds to the existing literature by asAing tCe DZ,.an )uesti,n3
about federal cosmetics law and regulation. Cosmetics are a highly gendered
*r,duHt and industrW. TCis #rtiHle uses tCe DZ,.an )uesti,n3 t, argue tCat bW
allowing cosmetics law and regulation to lag behind that of the other traditional
43. Bartlett, supra note 16, at 837.
44. Id.While different scholars have framed the questions somewhat differently, there is substantial
overlap in how they have done so. See, e.g., Heather Ruth Wishik, To Question Everything: The Inquiries
of Feminist Jurisprudence, 1 BERKELEYWOMEN’S L.J. 64, 72-76 (1985) (discussing seven questions, the
first four of which Dhelp . . . to identify how law and existence is gendered by patriarchy3 and the last
three of which Dinvolve the challenge of inventing, of imagining a world for which [there are] no givens3);
see also Lydia A. Clougherty, Feminist Legal Methods and the First Amendment Defense to Sexual
Harassment Liability, 75 NEB. L. REV. 1, 8 (1996) (discussing the essential features of the Dwoman
question3 and providing examples of questions that have been asked).
45. Bartlett, supra note 16, at 843.
46. Id. at 837.
47. See id. at 838; see also Clougherty, supra note 44, at 3 n.7 (listing law review articles that apply
the Dwoman question3 to different areas of the law).
48. Bartlett, supra note 16, at 838.
49. Dolly M. Trompeter, Sex, Drugs, and the Restatement (Third) of Torts, Section 6(c): Why
Comment E Is the Answer to the Woman Question, 48 AM. U. L. REV. 1139, 1145 (1999).
50. Claire A. Smearman, Drawing the Line: The Legal, Ethical and Public Policy Implications of
Refusal Clauses for Pharmacists, 48 ARIZ. L. REV. 469, 501 (2006).
51. See John A. Robertson, Asking the “Woman Question” About Health Care Reform, 3 TEX. J.
WOMEN&L. 1 (1994).
52. Breanne Sergent, Comment, To Include or to Exclude? The Policy Question Plaguing Women’s
Role in Clinical Trials, 34 J. LEGALMED. 235 (2013); Mary Anne Bobinski,Women and HIV: A Gender-
Based Analysis of a Disease and Its Legal Regulation, 3 TEX. J. WOMEN&L. 7, 56 (1994). And although
not explicitly identified as such, it has been asked about FDA’s drug approval process and women’s
representation in clinical trials. Christina Cole, Comment & Note, Women and the FDA: Remedying the
Past and Preserving the Future, 7 HOUS. J. HEALTH L. & POL’Y 127 (2006).
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product categories that FDA regulates under the FDCA and by failing to
adequately regulate cosmetics, Congress and FDA have left womenFand their
needs and experiencesFout of consideration, thereby jeopardizing their health.
However, at the same ti.e tCat tCis #rtiHle asAs tCe DZ,.an )uesti,nS3 it als,
recognizes that this method is not without its limitations and has been the subject
of critique.53
PirstS using DZ,.en3 as a Hateg,rW is *r,ble.atiH.54 It is too general in that
it obscures the fact that women and their experiences are not monolithic and
undifferentiated, and thus risks essentialism.55 Focusing on women as a category
,f analWsisS ZitC,ut reH,gniVing tCat Z,.en’s eX*erienHes are sCa*ed bW ,tCer
factors such as race, ethnicity, sexual orientation, and class, which intersect and
interaHt ZitC gender and sCa*e Z,.en’s eX*erienHes, excludes women who are
burdened on more than one dimension.56 For example, Kimberlé Crenshaw has
arguedZitC res*eHt t, blaHA Z,.en tCat D\b[eHause tCe interseHti,nal experience
is greater than the sum of racism and sexism, any analysis that does not take
intersectionality into account cannot sufficiently address the particular manner
inZCiHC "laHA Z,.en are sub,rdinated.357Of particular relevance to the current
analysisS #ngela 6. Narris Cas argued tCat D\t[Ce relati,n ,f blaHA Z,.en t, tCe
ideal ,f ZCite beautW is n,t a .,re intense f,r. ,f ZCite Z,.en’s frustrati,n: It
is something other, a complex mingling of racial and gender hatred . . . .358 These
other factors do not simply magnify the effects of gender, but intersect and
interaHt ZitC gender t, .,ld Z,.en’s eX*erienHes. TCe result ,f essentialis.S
Narris Cas arguedS Dis n,t ,nlW tCat s,.e ',iHes are silenHed in ,rder t, *ri'ilege
others . . . but that the voices that are silenced turn out to be the same voices
silenced by the mainstream legal voice . . . among them, the voices of black
Z,.en.359 Indeed, one longstanding critique of mainstream feminism and
fe.inist legal tC,ugCt is tCat tCeW *ri'ilege alreadW DraHe- and class-privileged
53. See Bartlett, supra note 16, at 837-49. As Bartlett notes, some may question whether the Dwoman
question3 is really just Da mask for something else, such as legal substance, or politics.3 Id. at 843-44. Just
because the method shapes substance, however, does not mean that it is substance. Id. Indeed, this is not
a distinguishing feature of the Dwoman question3 as a legal method as Dall legal methods shape substance.3
Id. at 844-45.
54. See, e.g., Martha Minow, Introduction: Finding Our Paradoxes, Affirming Our Beyond, 24
HARV. C.R.-C.L. L. REV. 1, 2 (1989).
55. See, e.g., Bartlett, supra note 16, at 872-73; Angela P. Harris, Race and Essentialism in Feminist
Legal Theory, 42 STAN. L. REV. 581, 615 (1990) (arguing Dthat gender essentialism is dangerous to
feminist legal theory because in the attempt to extract an essential female self and voice from the diversity
of women’s experience, the experiences of women perceived as 2different’ are ignored or treated as
variations on the (white) norm3).
56. Kimberle Crenshaw, Demarginalizing the Intersection of Race and Sex: A Black Feminist
Critique of Antidiscrimination Doctrine, 1989 U. CHICAGO L. FORUM 139; see also Bartlett, supra note
16, at 847.
57. Crenshaw, supra note 56, at 140.
58. Harris, supra note 55, at 597-98.
59. Id. at 585.
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Z,.en.360 TCere is als, a risA tCat tCe use ,f DZ,.an3 as a Hateg,rW .aW
Dreinstate . . . tCe is,lati,n and stig.atiVati,n ,f Z,.en.361
In tCe H,nteXt ,f tCe Hurrent analWsisS tCe use ,f DZ,.en3 as a Hateg,rW is
problematic because factors other than gender likely impacted the development
of cosmetics law. For example, many of the prominent advocates of reform were
white middle- and upper-class women who brought their respective values to
their reform work.62 TCe use ,f DZ,.en3 is als, *roblematic because different
women use and are exposed to cosmetics in different and particular ways, and
the risks that this exposure poses are shaped by a variety of factors; therefore,
the inadequate regulation impacts them in different and particular ways.63 Race,
ethnicity, sexual orientation, age, socio-economic status, and other factors
i.*aHt Z,.en’s eX*erienHes ZitC and eX*,sure t, H,s.etiHs and C,Z tCe
limitations of current cosmetics law and regulation impact them.64 For example,
the risks to an African American woman who uses chemical relaxers and deep
conditioners;65 a Vietnamese immigrant woman who works in a nail salon;66 and
a white woman who uses dark hair dyes may differ.67 Yet all of these women
may be exposed to risks from cosmetics.
"eHause DfaHt,rs ,tCer tCan gender 'iHti.iVe Z,.enS3 it is neHessarW t, asA
about other excluded groups.68 "artlett suggests reHasting tCe DZ,.an )uesti,n3
60. Crenshaw, supra note 56, at 140; see, e.g., bell hooks, Black Women: Shaping Feminist Theory,
in WORDS OF FIRE: AN ANTHOLOGY OF AFRICAN-AMERICAN FEMINIST THOUGHT 270 (Beverly Guy-
Sheftall ed., 1995); PATRICIAHILLCOLINS, BLACK FEMINIST THOUGHT: KNOWLEDGE, CONSCIOUSNESS,
AND THE POLITICS OFEMPOWERMENT (2d ed. 2000); ANGELAY.DAVIS, WOMEN, RACE&CLASS (1981);
Harris, supra note 55; Audre Lorde, Age, Race, Class, and Sex: Women Redefining Difference, in
FEMINIST THEORY: A READER 289, 290 (Wendy K. Kolmar & Frances Bartkowski eds., 2013); see also
Sojourner Truth, Ain’t I a Woman?, FORDHAM UNIVERSITY, MODERN HISTORY SOURCEBOOK (Dec.
1851), https://sourcebooks.fordham.edu/mod/sojtruth-woman.asp [https://perma.cc/236G-RH9X].
61. See Bartlett, supra note 16, at 835.
62. KAY, supra note 3, at 15, 17, 31; see also id. at 31-33 (discussing Dmorality of visible makeup3);
PEISS, supra note 3, at 7, 41 (discussing Dmorality of visible makeup3 and racial attitudes towards
cosmetics).
63. See infra Section II.B.1 & 2; see, e.g., Ami R. Zota & Bhavna Shamasunder, Viewpoint, The
Environmental Injustice of Beauty: Framing Chemical Exposures from Beauty Products as a Health
Disparities Concern, AM. J. OBSTETRICS & GYNECOLOGY 418, 418-20 (Oct. 2017) (discussing
D[p]reexisting vulnerabilities3 to and Dcumulative impacts3 of chemical exposures and the D[s]ocial and
economic dimensions of product use3); COMM. ON HEALTH CARE FOR UNDERSERVED WOMEN, AM.
COLL. OBSTETRICIANS & GYNECOLOGISTS, EXPOSURE TO TOXIC ENVIRONMENTAL AGENTS (2013),
https://www.acog.org/-/media/Committee-Opinions/Committee-on-Health-Care-for-Underserved-Wom
en/ExposuretoToxic.pdf [https://perma.cc/SVZ5-Y355] [hereinafter EXPOSURE TO TOXIC AGENTS]
(discussing how a number of factors can impact exposure to toxic environmental chemicals and health
disparities).
64. See Rhode, Feminist Critical Theories, supra note 35, at 622; Harris, supra note 55, at 587.
65. Adana AM Llanos et al., Hair Product Use and Breast Cancer Risk Among African American
and White Women, 38 CARCINOGENESIS 883 (Sept. 2017).
66. Cora Roelofs et al., Results from a Community-based Occupational Health Survey of
Vietnamese-American Nail Salon Workers, 10 J. IMMIGRANT & MINORITY HEALTH 353 (Aug. 2008),
https://www2a.cdc.gov/nioshtic-2/BuildQyr.asp?s1=20034386&View=e& [https://perma.cc/GH68-NB
9T]; NIOSH, NAIL TECHNICIANS’HEALTH, supra note 5.
67. Llanos et al., supra note 65.
68. Bartlett, supra note 16, at 847.
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as tCe D5uesti,n ,f tCe EXHludedS3 asAing C,Z DZ,.en and .e.bers ,f ,tCer
eXHluded gr,u*s3 Ca'e been left ,ut or disadvantaged.69 Thus, in considering the
DZ,.an )uesti,n3 in tCe H,nteXt ,f H,s.etiHs laZS tCis #rtiHle H,nsiders C,Z
DfaHt,rs ,tCer tCan gender 'iHti.iVe Z,.en3 and asAs ab,ut ,tCer eXHluded
gr,u*s sinHe DanalWsis ,f gender .ust ,HHur n,t a*art fr,. but within the
H,nteXts ,f .ulti*le identities.370 In addition, this Article tries to specify the
women to which it refers.71 Yet even the more specific categories which this
Article uses may be too general in that they risk other forms of essentialism.72
As Harris has remarked in critiquing gender essentialism by focusing on black
Z,.enS DCer ai. is n,t t, establisC a neZ essentialis. . . . based on the essential
eX*erienHe ,f blaHA Z,.en.373 Similarly, the aim of this Article is not to replace
gender essentialism with other forms of essentialism.
1sing DZ,.en3 as a Hateg,rW f,r analWsisS C,Ze'erS is als, t,, s*eHifiH.
Men also use and are exposed to cosmetics.74 The dangers and risks to human
health that cosmetics may pose cannot be controlled by only focusing on
women.75 The reforms that this Article proposes in the final Part are likely to
have broader benefits in terms of understanding and assessing the risks of
cosmetics.
#sAing ab,ut C,Z H,s.etiHs laZ and regulati,n i.*aHt DZ,.en3 Hreates
the illusion of a binary worldFwoman or man, female or male, feminine or
masculineFwhich fails to account for the complexities of sex and gender.76
69. Id. at 831, 847-48.
70. Id. at 847.
71. See id. at 848 (stating tCat DanW analWsis using tCe general Hateg,rW ,f Z,.an is itself
eXHlusi,narW3 and disHussing E. SPELMAN, INESSENTIAL WOMAN: PROBLEMS OF EXCLUSION IN FEMINIST
THOUGHT (1988),ZCiHCS aHH,rding t, "artlettS Dsuggests tCat in s*eaAing ,f 2Z,.enS’ tCe s*eaAer sC,uld
na.e eX*liHitlW ZCiHC Z,.en sCe .eans3).
72. See Harris, supra note 55, at 585; Bartlett, supra note 16, at 848 (DAny category, no matter how
narrowly defined, makes assumptions about the remaining characteristics of the group that fail to take
account of members of the group who do not have those characteristics.3); see also Harris, supra note 55,
(DMy suggestion is only that we make our categories explicitly tentative, relational, and unstable. . . .3).
73. See Harris, supra note 55, at 585.
74. Envtl. Working Group (EWG), Exposures Add Up&Survey Results, https://www.ewg.org/skin
deep/2004/06/15/exposures-add-up-survey-results/#.W1IiAC_GwXo [https://perma.cc/VGC4-BZBX]
[hereinafter EWG, Exposures Add Up]; see alsoMeredith Melnick,Men’s Grooming Products: Are They
Really Any Different From Women’s?, HUFFINGTON POST (Feb. 9, 2012), https://www.huffington
post.com/2012/02/09/mens-grooming-products-different-womens_n_1264137.html [https://perma.cc/Q5
BL-R7ES].
75. SeeMinow, supra note 54, at 2.
76. See, e.g., Sara R. Benson, Hacking the Gender Binary Myth: Recognizing Fundamental Rights
for the Intersexed, 12 CARDOZO J.L. &GENDER 31 (2005) (discussing the rights of intersexed people and
D[t]he gender binary model [which] posits that only two sexes exist and that every person must fit easily
into the category of male or female3 and arguing for a right to gender identity, which would recognize Da
variable spectrum of gender induced identities3); Katie Reineck, Note, Running from the Gender Police:
Reconceptualizing Gender to Ensure Protection for Non-Binary People, 24 MICH. J. GENDER & L. 265,
266 (2017) (noting that Dnon-binary peopleFwho do not identify within the accepted gender binary as
men or women. . . . may present in a way typically associated with women, by wearing makeup, keeping
their hair long, or wearing clothing sold in the women’s section; in a way typically associated with men,
by keeping their hair short, growing facial hair, or wearing clothing sold in the men’s section; or may
present androgynously by mixing elements of the two3).
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Although sex and gender have often been conflated in the law,77 many have
argued tCat tCese sC,uld be distinguisCedS as seX is n,t genderS but D.erelW ,ne
H,.*,nent3 ,f it.78 Especially relevant to the current analysis is the fact that
transgender and non-binary individuals use cosmetics and thus are impacted by
the state of cosmetics law and regulation.79
_es*ite tCe li.itati,ns ,f tCe DZ,.an )uesti,nS3 it is a useful fra.e ,f
analWsis and Dit still .aAes sense t, talA ab,ut 2Z,.en.’380 First, imperfect as
these categories are, analyzing cosmetics law and regulation using categoriesF
inHluding DZ,.en3Fhelps to illuminate the shortcomings of the current
regulatory approach.81 Second, the current analysis is constrained by the
limitations of the existing data, information, and scholarship that it examines.
ManW ,f tCese s,urHes use DZ,.en3 as a Hateg,rW and refleHt a binarW
understanding of gender. Nuanced gender information is often unavailable and
sources addressing cosmetics, their use, and the people that influenced early
reform efforts largely do so within a binary framework.82 There is a need for
explicit examination of how cosmetics law and regulation have impacted and
continue to impact transgender and gender non-conforming individuals. As the
cosmetics industry is beginning to explicitly recognize, many transgender and
gender non-conforming individuals use cosmetics.83
77. See Rhode, Feminist Critical Theories, supra note 35, at 617-18; see also Case, supra note 35,
at 6; Bell, supra note 35, at 1716 (discussing distinctions between gender and sex).
78. See Adam R. Chang & Stephanie M. Wildman, Gender In/sight: Examining Culture and
Constructions of Gender, 18 GEO. J. GENDER&L. 43, 54 (2017) (noting that D[a]n increasing number of
educators and scholars presently explain gender as being a combination of sex, gender identity, and gender
expression3); see generally JUDITH BUTLER, GENDER TROUBLE: FEMINISM & THE SUBVERSION OF
IDENTITY (1990).
79. See, e.g., Rachel Lubitz, Is “Gender-Neutral” Just A Beauty Buzzword&Or Something Greater?,
REFINERY29.COM (Aug. 22, 2018 2:00 PM), https://www.refinery29.com/en-us/gender-neutral-makeup-
beauty-brands [https://perma.cc/LK2K-2GAA] (stating that people with different gender expression have
used makeup but that new brands are Dsignaling . . . that everyone, including cis women, cis men, and
transgender, gender non-conforming, non-binary, and gender-fluid individuals, can be their customers and
use their products3); Classes for Confidence, SEPHORA STANDS, https://www.sephorastands.com/
classes_for_confidence/ [https://perma.cc/HY3N-ELWP] (indicating that beauty retailer Sephora offers
beauty classes in its participating stores entitled DBold Beauty for the Transgender Community3).
80. Christine A. Littleton, Does It Still Make Sense to Talk About “Women”?, 1 UCLA WOMEN’S
L.J. 15, 16 (1991). This Article uses the term Dwomen3 largely to refer to people who others (e.g.,
legislators, regulators, medical professionals, and scholars) have regarded as women, similar to how
Christine A. Littleton Duse[s] the term 2women’ to refer to people who are regarded by those in
power . . . as women.3 Id. at 16.
81. Harris, supra note 55, at 582 (DTo think is to forget differences, generalize, make abstractions.3).
82. See, e.g., infra Section II.A (discussing cosmetics usage and pressures on women to use
cosmetics); infra Section III.A.1 & 2 (arguing that cosmetics law and regulation have been deprioritized
as a result of women’s exclusion from political participation and representation and because of their
longstanding and close association with femininity and women).
83. See, e.g., Ivana Rihter, How 4 Next-Gen Makeup Lines are Serving the Transgender Community,
VOGUE.COM (July 30, 2018, 4:57 PM), https://www.vogue.com/article/transgender-community-beauty-
tutorials-makeup-skin-brands-sephora-fluide [https://perma.cc/J857-EV76] (noting that Deven though it
may seem like makeup has long been at the center of the queer community, often considered a tool for
self-expression, identification, and reinvention, most transgender people 2don’t feel included in the beauty
world’3 and discussing Dgender nonbinary brands and charities that are supporting members of the
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TCis inf,r.ati,n defiHit relates t, an,tCer feature ,f tCe DZ,.an )uesti,n3
tCat sC,uld be aHAn,Zledged fr,. tCe ,utset. #s a legal .etC,d tCe DZ,.an
)uesti,n3 Dneither guarantees a *artiHular result n,r e'en tCe rigCt result.384
Accordingly, it Dd,es n,t re)uire deHisi,n in fa',r ,f a Z,.anS3 but ratCer seeAs
t, eX*,se Dinterests and H,nHerns tCat ,tCerZise .aW beS and Cist,riHallW Ca'e
beenS ,'erl,,Aed.385 Accordingly the reforms that this Article suggests in the
final Part are aimed at providing additional information in order to better assess
the risks that the current regulatory approach poses. This Article proceeds
mindful of the limitations of its chosen method.
II. THEGENDERED&RACIALIZED IMPACT OF THE CONTEMPORARY
APPROACH TO THE REGULATION OF COSMETICS
This Part begins by discussing the gendered nature of cosmetics in the
United States. Although men use cosmetics, cosmetics are strongly associated
with women and femininity, and, on average, women use more cosmetics.
Cosmetics use is also shaped by factors other than gender, including race,
ethnicity, socioeconomic status, and age. This Part also discusses the risks to
Z,.en’s CealtC tCat H,s.etiHs .aW *,se and C,Z such risks may be shaped by
factors other than gender. It argues that because cosmetics are a highly gendered
product and industry, failures in cosmetics law and regulation may
disproportionately jeopardize the health of women, particularly women who are
members of other excluded groups. This Part then provides an overview of the
cosmetics provisions of the Federal Food, Drug, and Cosmetic Act of 1938
(FDCA), which largely remain unchanged. Finally, it examines current
cosmetics law and regulation and how they lag behind the law and regulation for
other major product categories regulated under the FDCA.
A. Gender, Race, Class & Cosmetics
Cosmetics are a highly gendered product and industry. On average, women
use more cosmetics than men.86 For example, one surveW f,und tCat D\t[Ce
LGBTQ+ community3); Vanessa Chesnut, Not Your Mama’s Makeup: New Cosmetics Target Consumers
Across Gender Spectrum, NBC NEWS (May 11, 2018 4:08 PM), https://www.nbcnews.com/feature/nbc-
out/not-your-mama-s-makeup-new-cosmetics-target-consumers-across-n873386 [https://perma.cc/6WX
A-9E33] (stating that Da growing number of transgender, gender-nonconforming and male identified
people . . . are seeking out gender-inclusive makeup products, and companiesFboth old and newFare
responding to their demand3).
84. Bartlett, supra note 16, at 849.
85. Id. at 846.
86. There is, however, a Dgrowing permissibility3 of cosmetics and hair dye for straight men. ROBIN
TOLMACHLAKOFF&RAQUELL. SCHERR, FACEVALUE: POLITICS OFBEAUTY 224 (1989); see also Jacob
Gallagher, More Men Are Wearing Makeup Than You Think&Here’s Why, WALL ST. J. (Apr. 13, 2018),
https://www.wsj.com/articles/more-men-are-wearing-makeup-than-you-thinkheres-why-1523626771
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a'erage Z,.an uses @? *r,duHts H,ntaining @;9 uni)ue ingredients e'erW daWS3
ZCereas tCe a'erage.an Duse\s[ ; *r,duHts dailW ZitC 9< uni)ue ingredients.387
Another poll found that 54 percent of male respondents indicated that they use
n, DsAin Hare and stWling *r,duHts UsuHC as .,isturiVersS Cair stWling *r,duHtsS
and makeup) . . . t, get readW in tCe .,rning ,n a tW*iHal daW3 ZCereas ,nlW @;
percent of female respondents indicated they use no products.88 A larger portion
of women than men indicated that they use three or more products (45 percent
vs. 11 percent).89 And as noted earlier, most women (86 percent) use makeupF
a type of cosmetic.90
Cosmetics use may not be voluntary for women. For example, employers
may have gendered employee dress codes that require femaleFbut not maleF
employees to wear makeup.91 And even when employers do not require women
to use cosmetics, women may face other pressures to do so.92 For example,
cosmetics use can impact how people perceive themselves and are perceived by
others and may have significant effects on both interpersonal relationships and
economic opportunities.93
Women also may be exposed to cosmetics through their employment.
Women are significantly more likely than men to hold certain jobs that often
involve exposure to cosmetics as beauty work is often done for women by
[https://perma.cc/TAN8-UNVX]; PEISS, supra note 3, at 265. The men’s grooming and personal care
products industry in the United States has grown in recent years. See, e.g., MEN’S PERSONALCARE, supra
note 3.
87. EWG, Exposures Add Up, supra note 74.
88. Survey, YOUGOV (Sept. 10G11, 2013), http://cdn.yougov.com/cumulus_uploads/document/
ypg8eyjbsv/tabs_skincare_0910112013.pdf [https://perma.cc/UR2N-ZRFA] (surveying subjects regard-
ing their morning and evening routines, as well as the cosmetics products used in the process).
89. Id. The number of products used varied by other factors including age, race, and education. Id.
90. COLOR COSMETICS, supra note 6; FDCA § 201(i), 21 U.S.C. § 321(i).
91. See Jespersen v. Harrah’s Operating Co., 392 F.3d 1076 (9th Cir. 2004). Jespersen v. Harrah’s
Operating Co. was a case that involving a female bartender who was fired for refusing to wear makeup in
violation of her employer’s appearance standards. Id. Her case was not successful. Id. The Ninth Circuit
Court of Appeals affirmed the grant of summary judgment to the employer; it held that the employee
failed to establish a prima facie case of gender discrimination under Title VII of the Civil Rights Act of
1964. Id. Employer dress codes may have class implications.
92. Beauty serves as a Dproxy for status and ability.3 Nancy L. Etcoff et al., Cosmetics as a Feature
of the Extended Human Phenotype: Modulation of the Perception of Biologically Important Facial
Signals, 6 PLOS ONE e25656 (Oct. 2011), http://journals.plos.org/plosone/article?id=10.1371/journal.
pone.0025656#pone.0025656-Etcoff2 [https://perma.cc/6HK5-8YMS]. However, beauty is malleable.
Lauren Silverio,Makeup’s Effects on Self-Perception (Old Dominion Univ., STEM Educ. & Prof’l Stud.,
OTS Master’s Level Projects & Papers 49, 2010), https://digitalcommons.odu.edu/cgi/viewcontent.cgi?
article=1048&context=ots_masters_projects [https://perma.cc/4JPT-HKEJ]. For example, one study
found that study participants D[w]hen inferring trustworthiness, likeability, or competence from an image3
of a woman, were Dinfluenced significantly3 not only by inherited features Dbut by the effects
of . . . makeup.3 Etcoff, supra.
93. Kirsten Dellinger & Christine L. Williams, Makeup at Work: Negotiating Appearance Rules in
the Workplace, GENDER & SOC’Y 151, 153 (1997); Deborah L. Rhode, The Injustice of Appearance, 61
STAN. L. REV. 1033, 1037-38 (2009). Cosmetics may also be a source of pleasure. See, e.g., PEISS, supra
note 3, at 269.
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women.94 For example, in 2017, 92.6 percent of hairdressers, hairstylists, and
cosmetologists were women.95 In addition, 90.5 percent of the people employed
in beauty salons were women, as were 73.9 percent of those in nail salons and
other personal care services.96
Factors other than gender also impact cosmetics use and exposure.
Cosmetics usage and exposure differ among women of different racial and ethnic
groups.97 For example, African #.eriHans’ s*ending ,n *ers,nal Hare *r,duHts
as a portion of the total market, according to one estimate, exceeds their portion
,f tCe 1.S. *,*ulati,nS ZCiHC Dsuggest\s[ tCat tCeW buW and use .,re suHC
*r,duHts.398 Another study similarly found that African American women spend
80% more than the general market on cosmetics, and two times that of other
ethnic groups on hair products.99
Indeed, there also may be racial differences in the types of cosmetics women
use.100 For example, many African American girls have chemical relaxers
applied to their hair for the first ti.e during HCildC,,d and D#friHan
American . . . women are more likely [than white women] to use a greater
number and variety of hair products, and to have their hair chemically or
professionally treated.3101 In additi,nS D"laHA Z,.en are .,re liAelW . . . to use
vaginal douches as well as other fragranced feminine cleansing products such as
s*raWs and Zi*es.3102
94. PEISS, supra note 3; KAY, supra note 3. While the economic opportunities in the cosmetics
industry provides should not be minimized, it is important to recognize that these opportunities may be
accompanied by workplace exposure to the cosmetics and associated risks. See infra Section II.B.
95. BLS, DETAILEDOCCUPATION, supra note 6. Of those 76.7% were white, 16.3% Hispanic/Latina,
13.5% black, and 5.6% Asian. Id.
96. BUREAU OF LABOR STATISTICS, EMPLOYED PERSONS BYDETAILED INDUSTRY, SEX, RACE, AND
HISPANIC OR LATINO ETHNICITY tbl.18 https://www.bls.gov/cps/cpsaat18.htm [https://perma.cc/D5XD-
TBBB] [hereinafter BLS, DETAILED INDUSTRY].
97. Zota & Shamasunder, supra note 63, at 418G20 (noting that D[w]orkers in the beauty industry,
who are predominately women of color and immigrant women, can . . . face occupational health hazards
from chemicals in professional cosmetic products3).
98. PAUL PESTANO ET AL., ENVIRONMENTAL WORKING GROUP, BIG MARKET FOR BLACK
COSMETICS, BUT LESS-HAZARDOUS CHOICES LIMITED (2016), http://www.firstresearch.com/Industry-
Research/Personal-Care-Products-Manufacturing.html [https://perma.cc/4HHC-TR2T].
99. See Stephanie D. Smith, Essence Panel Explores Beauty Purchasing, WWD (May 19, 2009),
https://wwd.com/beauty-industry-news/color-cosmetics/essence-panel-explores-beauty-purchasing-
2139829/ [https://perma.cc/7Z58-AQYG]; Rajiv Shah &Kelly E. Taylor, Note, Concealing Danger: How
the Regulation of Cosmetics in the United States Puts Consumers at Risk, 23 FORDHAM ENVTL. L. REV.
203, 212 (2012); see also Tamarra James-Todd et al., Racial/Ethnic Differences in Hormonally-Active
Hair Product Use: A Plausible Risk Factor for Health Disparities, 14 J. IMMIGRANT & MINORITY
HEALTH 506 (2012) (finding that African American and African-Caribbean women from the New York
metropolitan area were more likely to be exposed to hormonally-active chemicals in hair products
compared to white women); Zota & Shamasunder, supra note 63.
100. Dark-skinned women of various races may disproportionately use skin lightening creams,
which have several potential adverse outcomes. See Zota & Shamasunder, supra note 63, at 419 (table);
see also Imani Perry, Buying White Beauty, 12 CARDOZO J.L. & GENDER 579, 590-91 (2006) (discussing
skin-bleaching creams and stating that D[t]he whitening of the world’s wealthy is a much safer affair than
that of its poorer, and blacker, populations3).
101. Zota & Shamasunder, supra note 63, at 419.
102. Id. at 420.
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There also may be significant racial differences in employment in certain
jobs that involve the use of cosmetics. For example, while 76.7 percent of
hairdressers, hairstylists, and cosmetologists are white and 5.6 percent are
Asian,103 only 44.8 percent ,f *e,*le e.*l,Wed in Dnail sal,ns and ,tCer *ers,nal
Hare ser'iHes3 are ZCite and =;.> percent are Asian.104
Furthermore, there may be class differences between beauty workers and
customers. For example, in The Managed Hand: Race, Gender, and the Body in
Beauty Service WorkSMiliann Kang DeX*l,re\s[ H,..,nalities and differenHes3
among Asian immigrant women in the nail salon industry in the United States.105
SCe disHusses C,Z nail sal,ns bring DZ,.en ZC, usuallW Z,uld n,t find
tCe.sel'es in tCe sa.e s,Hial HirHles3 int, Hl,se *CWsiHal H,ntaHt and C,Z tCese
interaHti,ns Dde.,nstrate C,Z Z,.en inCabit b,dies differently as well as how
Z,.en’s b,dies are differentiallW 'alued and e.*l,Wed.3106 Kang explores how
genderS raHeS and Hlass interaHt in nail sal,ns tCr,ugC DtCree different f,r.s ,f
body labor at Asian-,Zned nail sal,ns: 2*a.*ering b,dW lab,r’ in nail art salons
serving mostly white upper-[ ]and middle-Hlass Z,.en% 2eX*ressi'e b,dW lab,r’
in nail art salons serving mostly black working-and lower-middle-class women;
and 2r,utiniVed b,dW lab,r’ at disH,unt nail sal,ns ser'ing raHiallW and
s,Hi,eH,n,.iHallW .iXed Hust,.ers.3107
B. Cosmetics Safety
TCe H,s.etiHs industrW and P_# Ca'e stated tCat D\H[,s.etiHs are tCe safest
*r,duHts tCat P_# regulates.3108 But even if cosmetics are the safest products
that the agency regulates, cosmetics are not necessarily safe, as the harms caused
by other products that FDA regulates are well-documented.109
103. BLS, DETAILEDOCCUPATION, supra note 6.
104. BLS, DETAILED INDUSTRY, supra note 96.
105. MILIANN KANG, THE MANAGED HAND: RACE, GENDER, AND THE BODY IN BEAUTY SERVICE
WORK 11-12 (2010) (ebook). Kang’s work focuses on Korean women working in the nail salon industry
in New York City. Id. at 12.
106. Id. at 11-12.
107. Id. at 16.
108. See, e.g., Before the Subcomm. on Health of the H. Comm. on Energy & Commerce, 112th
Cong. (2012) (statement of Peter Barton Hutt, Senior Counsel, Covington & Burling, LLP),
https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearing
s/Health/20120327/HHRG-112-IF14-WState-HuttP-20120327.pdf [https://perma.cc/MU6J-STYJ]; Befo-
re the Subcomm. on Health of the H. Comm. on Energy & Commerce, 112th Cong. (2012), (Statement of
Halyna Breslawec, Chief Scientist & Exec. Vice President for Sci., Pers. Care Prod. Council), https://
archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Healt
h/20120327/HHRG-112-IF14-WState-BreslawecH-20120327.pdf [https://perma.cc/PDS4-Q7YD]; Peter
Barton Hutt, The State of Science at the Food and Drug Administration, 60 ADMIN. L. REV. 431, 461
(2008).
109. See FDCA § 301, 21 U.S.C. § 331 (2012) (prohibiting certain acts with respect to Dany food,
drug, device, tobacco product, or cosmetic3); U.S. FOOD&DRUGADMINISTRATION, FOOD, https://www.
fda.gov/Food/default.htm [https://perma.cc/N3RM-TMCM] (food); U.S. FOOD AND DRUG
ADMINISTRATION, DRUGS, https://www.fda.gov/Drugs/default.htm [https://perma.cc/57BA-VK7R]
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While a comprehensive review of the literature on cosmetics safety is
beyond the scope of this Article,110 there is reason to be concerned about the
potential hazards that cosmetics may pose. Other legal scholars and
commentators have discussed the potential risks of a host of cosmetics products,
ingredients, and contaminates, including phthalates, permanent hair relaxers,111
spray tan solutions,112 tattoos and micropigmentation inks,113 henna (and henna
containing PPD and lead),114 nail salon products,115 nanoparticles,116 and
chemicals that have the potential to disrupt the human endocrine system.117 The
potential hazards that the literature discusses vary, and include severe scalp
burns, early puberty in girls, premature delivery, adverse effects on male
reproductive development, and cancer.118
Women may be disproportionately impacted due to differences in exposure.
As noted earlier, on average, women use more cosmetics than men and are
exposed to more chemicals than men through this use.119 Women may also be
eX*,sed t, H,s.etiHs tCr,ugC tCeir Z,rAS as DbeautW Z,rA3 is ,ften d,ne bW
women.120 Women also may be uniquely vulnerable to potential health harms
fr,. HCe.iHal eX*,sure. P,r eXa.*leS Z,.en’s b,dies .aW Dst,re HCe.iHals
Hu.ulati'elW .,re effeHti'elW tCen .en’s b,diesS *laHing Z,.en at greater
(drugs); U.S. FOOD AND DRUG ADMINISTRATION, TOBACCO PRODUCTS, https://www.fda.gov/
TobaccoProducts/default.htm [https://perma.cc/4DMF-3NUV] (tobacco products); supra note 13
(discussing harms of drugs, foodborne diseases, and cigarettes).
110. The focus of this Article is on physical risks, but cosmetics may pose economic harms as well.
See Bryan A. Liang & Kurt M. Hartman, It’s Only Skin Deep: FDA Regulation of Skin Care Cosmetics
Claims, 8 CORNELL J.L. & PUB. POL’Y 249, 250 (1999) (DHowever, the FDA’s focus on physical safety,
and its attempted designation of skin care cosmetics as drugs, has ignored the significant responsibility of
the agency to protect the public against highly questionable efficacy claims by certain cosmetics
manufacturers.3); Amity Hartman, FDA’s Minimal Regulation of Cosmetics and the Daring Claims of
Cosmetic Companies That Cause Consumers Economic Harm, 36 W. ST. U. L. REV. 53, 54 (2008) (DThe
current regulatory scheme does not always give consumers adequate economic protection.3).
111. Shah & Taylor, supra note 99, at 210G14.
112. Jessica M. Dugdale, A Plea for Consumer Protection: The Potential Human Health Hazards of
the Spray Tanning Epidemic, 11 IND. HEALTH L. REV. 347, 359-60 (2014).
113. Jessica C. Dixon, The Perils of Body Art: FDA Regulation of Tattoo and Micropigmentation
Pigments, 58 ADMIN. L. REV. 667, 682 (2006).
114. Carrie Griffin Basas,Henna Tattooing: Cultural Tradition Meets Regulation, 62 FOOD&DRUG
L.J. 779, 791 (2007).
115. Sarah A. Walsh, Beyond the Polish: An Examination of Hazardous Conditions in Nail Salons
and Potential Solutions for the Industry in New York City, 21 J.L. & POL’Y 243, 256-60 (2012).
116. Gregory Mandel, Nanotechnology Governance, 59 ALA. L. REV. 1323, 1340-44 (2008); Donald
R. Johnson, Not in My Makeup: The Need for Enhanced Premarket Regulatory Authority over Cosmetics
in Light of Increased Usage of Engineered Nanoparticles, 26 J. CONTEMP. HEALTH L. & POL’Y 82, 94-
102 (2009); Robin Fretwell Wilson, Nanotechnology: The Challenge of Regulating Known Unknowns, 34
J.L. MED. & ETHICS 704, 705-06, 708-09 (2006).
117. Valerie J. Watnick, The Missing Link: U.S. Regulation of Consumer Cosmetic Products to
Protect Human Health and the Environment, 31 PACE ENVTL. L. REV. 595, 607-11 (2014); Anastasia De
Paz, The Cosmetic Regime Needs A Makeover: Advocating to Empower the FDA Through the Safe
Cosmetics Act of 2011, 31 TEMP. J. SCI. TECH. & ENVTL. L. 337, 340-42 (2012).
118. See, e.g., Shah & Taylor, supra note 99, at 211G18.
119. See supra Section II.A.
120. PEISS, supra note 3; KAY, supra note 3; supra note 69 and accompanying text; supra Section
II.A.
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risA.3121 Women of reproductive age and their offspring may be at particular risk
fr,. tCese eX*,suresS as D*reH,nHe*ti,n and *renatal eX*,sure t, t,XiH
environmental agents can have a profound and lasting effect on reproductive
CealtC aHr,ss tCe life H,urse.3122
Women who are members of other excluded groups may be at even greater
risk. These women may use or otherwise be exposed to more cosmetics,
including particular types of cosmetics, as cosmetics usage and work are not only
gendered, but also differ by race.123
The cosmetics that women who are members of other excluded groups are
exposed to also may be more hazardous. For example, Imani Perry suggests that
DtCe a'ailabilitW ,f teHCn,l,giHal res,urHes is CigCer f,r tC,se ZC, are alreadW
*ri'ileged3 and tCat tCis .aW reinf,rHe eXisting CierarHCies: D\i[f ,ne Han aff,rd
to . . . purchase the gentler products, the odds are that the person is already closer
t, tCe \beautW[ ideal.3124 7ne analWsis f,und tCat D\a[ s.aller sCare ,f Cair and
beauty products marketed to Black women scored low in potentially harmful
ingredients than produHts ai.ed at tCe general *ubliH.3125 Cosmetics have been
associated with health hazards in women of color.126 For example, one study
found an association between using hair dye more than twice a year, use of dark
hair dye shades, and salon application of hair dyes and the risk of estrogen-
positive breast cancer in African American women.127
Some women may have greater exposure to toxic environmental chemicals
due to a variety of factors. A report by the Committee on Health Care for
Underserved Women of the American College of Obstetricians and
OWneH,l,gists n,tes tCat DCar.ful en'ir,n.ental eX*,sure is ine)uitablW and
unequally distributed, which leaves some populations, including underserved
121. De Paz, supra note 117, at 341.
122. Id.; Shah & Taylor, supra note 99, at 209. One analysis found that women ages eighteen to
thirty-fourFwomen of reproductive ageFare more likely to be Dthe heaviest buyers of cosmetics.3
Millennial Women Key to Growth in Cosmetics Industry, TABS ANALYTICS BLOG (Jan. 20, 2016),
https://www.tabsanalytics.com/blog/millennial-women-key-to-growth-in-cosmetics-industry [https://per
ma.cc/Y2NX-S7WP]; see also AM. COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS COMM. ON
GYNECOLOGIC PRAC., COMMITTEE OPINION, NUMBER 589, FEMALE AGE-RELATED FERTILITY DECLINE
(Mar. 2014 reaffirmed 2018), https://www.acog.org/Clinical-Guidance-and-Publications/Committee-
Opinions/Committee-on-Gynecologic-Practice/Female-Age-Related-Fertility-Decline
[https://perma.cc/M4HU-YF75] (discussing age and fertility).
123. See Perry, supra note 100, at 588; see also Zota & Shamasunder, supra note 63.
124. Perry, supra note 100, at 595.
125. PESTANO ET AL., supra note 98.
126. See, e.g., Lauren A. Wise et al., Hair Relaxer Use and Risk of Uterine Leiomyomata in African-
American Women, 175 AM. J. EPIDEMIOLOGY 432, 435 (2012) (finding Dincreased risks of uterine
leiomyomata in association with ever use of hair relaxers, duration of use, frequency of use, and total
number of burns experienced during use3); Jasmine A. McDonald et al., Hair Product Use, Age at
Menarche and Mammographic Breast Density in Multiethnic Urban Women, 17 ENVIRON. HEALTH 1, 8
(2018) (concluding that Dchildhood hair product use is associated with earlier age at menarche, an
established risk factor for breast cancer3).
127. Llanos et al., supra note 65, at 888. The study also found an association between certain hair
products and breast cancer in white women. Id. The study noted that there are differences in product use
among African American and white women. Id.
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women, more vulnerable to adverse reproductive health effects than other
*,*ulati,ns.3128 The exposure sources listed for some of the chemicals linked to
negative reproductive or developmental health effects in the report include
cosmetics and personal care products.129 D\"[eautW *r,duHt use .aW be ,ne ZaW
that structural discriminati,n beH,.es bi,l,giHallW e.beddedS3 as raHial
disHri.inati,n Han influenHe *r,duHt use and D\t[argeted raHialRetCniH .arAeting
Han influenHe *r,duHt use and related CealtC ine)uities.3130
Some workplaces may expose the women who work in them to high levels
of potentially toxic chemicals from cosmetics.131 For example, one study of
Vietna.ese Z,.en Z,rAing in nail sal,ns in !alif,rnia n,ted tCat D\n[ail
technicians handle solvents, glues, polishes, and other agents on a daily basis
exposing them to numerous chemicals, many of which are known or suspected
to cause cancer, allergies, and respiratory, neurologic, and reproductive
Car..3132 The study measured levels of total volatile organic compounds that
eXHeed tCe En'ir,n.ental 6r,teHti,n #genHW’s reH,..ended le'els and were
Din tCe range . . . at ZCiHC discomfort is expected and complaints of health
symptoms, including headaches and irritations of the eyes, nose, and throat, are
H,..,n.3133
Because of differences in usage, exposure, and biology, women may be
subject to greater risk from exposure to toxic chemicals in cosmetics than men
are. As a result, any regulatory failure to control these risks may
disproportionately impact women. Furthermore, because of differences in usage
and exposure, women who are members of other excluded groups may be at
particular risk. This Article now turns to the shortcomings of cosmetics law and
regulation.
C. Cosmetics Law & Regulation
Despite significant changes in the law with respect to the other major
product categories under FDA’s BurisdiHti,nS tCe P_!#’s H,s.etiHs *r,'isi,ns
have remained largely unchanged since the Act was passed in 1938. This Section
begins with an overview of the 1938 Act. It then discusses the current laws and
regulations with an emphasis on the changes since the FDCAwas enacted. It also
discusses the cosmetics industrW’s self-regulatory measures and how FDA
128. EXPOSURE TO TOXICAGENTS, supra note 63, at 1.
129. Id. at 3-4 tbl.2.
130. Zota & Shamasunder, supra note 63, at 419.
131. Women who receive services in these locations may also be exposed to potentially toxic
chemicals although likely for shorter time periods than workers. Cosmetics intended for professional use
only are less regulated than those intended for consumer use, which may also lead to differences in
exposure. See supra Section II.2.dGe.
132. Thu Quach et al., Characterizing Workplace Exposures in Vietnamese Women Working in
California Nail Salons, 101 AM. J. PUB. HEALTH S271, S271 (2011).
133. Id. at S274.
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regulates cosmetics in this environment. This Section ends by highlighting
several significant differences between how cosmetics and other products are
regulated. It argues that the divide between cosmetics law and regulation and the
law and regulation of the other major product categories defined in the FDCA
has grown since the 1938 Act was first enacted. These changes have deprioritized
the regulation of cosmetics, the product category most closely associated with
women. The limitations of cosmetics law and regulation hinder the ability to
meaningfully assess the safety of cosmetics.
The Federal Food, Drug & Cosmetic Act of 1938
The 1938 FDCA created the first federal law for the regulation of
cosmetics.134 As discussed in Section I.AS H,s.etiHs are DartiHles intended t, be
rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied
to the human body or any part thereof for cleansing, beautifying, promoting
attraHti'enessS ,r altering tCe a**earanHeS3 inHluding artiHles intended t, be a
component of those articles, but not soap.135
The FDCA prohibited certain acts related to the misbranding and
adulteration of cosmetics as well as the causing of those acts provided that certain
interstate commerce connections were met.136 The FDCA provided that a
H,s.etiH is adulterated if it DH,ntains any poisonous or deleterious substance
which may render it injurious to users under the conditions of use prescribed in
the [its] labeling . . . ,r under suHC H,nditi,ns ,f use as are Hust,.arW ,r usualS3
but it excepted coal-tar hair dyes that comply with certain labeling
requirements.137 TCe P_!# als, *r,'ided tCat a H,s.etiH tCat DH,nsists inZC,le
or in part of any filthy, putrid, or decomposed substanHe3 ,r tCat DCas been
prepared, packed, or held under insanitary conditions whereby it may have
become contaminated with filth, or whereby it may have been rendered injurious
t, CealtCS3 is adulterated.138 # H,s.etiH’s H,ntainer H,uld als, render tCe
H,s.etiH adulterated if tCe DH,ntainer is H,.*,sedS in ZC,le ,r in *artS ,f anW
poisonous or deleterious substance which may render the contents injurious to
CealtC.3139 The FDCA also provided that a cosmetic other than a hair dye
containing a coal-tar color that had not been properly batch certified is
adulterated.140
134. See Federal Food, Drug, and Cosmetic Act (FDCA), Pub. L. 75-717, 52 Stat. 1040 (June 25,
1938).
135. Id. § 201(i). The definition of cosmetics in the original Act has remained unchanged. Compare
id., with FDCA § 201(i), 21 U.S.C. § 321(i) (2012).
136. FDCA § 301 (1938).
137. Id. § 601(a).
138. Id. § 601(b)-(c).
139. Id. § 601(d).
140. Id. § 601(e).
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The FDCA also provided that a cosmetic with labeling tCat Dis false ,r
.isleading in anW *artiHular3 is .isbranded.141 A packaged cosmetic is also
.isbranded if it d,es n,t bear a label ZitC DtCe na.e and *laHe ,f business ,f
tCe .anufaHturerS *aHAerS ,r distribut,rS3 and Dan aHHurate state.ent ,f tCe
quantitW3 ,f H,ntents.142 Other misbranding provisions addressed the
prominence of required information and misleading containers.143
Current Law & Regulation
a. The Federal Food, Drug & Cosmetic Act of 1938 as Amended
SinHe @8>9S tCe P_!#’s H,s.etiHs *r,'isi,ns have changed little. The
FDCA has grown from about 10 pages to nearly 500,144 yet the cosmetics
provisions remain less than two pages.145 As in the original act, the current
cosmetics provisions focus on prohibiting the certain acts related to the
adulteration and misbranding of cosmetics,146 and like the original act, they
except coal-tar hair dyes from the adulteration provision for cosmetics
containing any poisonous or deleterious substance.147
141. Id. § 602(a).
142. Id. § 602(b).
143. Id. § 601(c)-(d).
144. Compare 21 U.S.C. §§ 301-392 (1938 supp. IV), with 21 U.S.C. ch. 9 (2012).
145. See generally FDCA, 21 U.S.C. ch. 9 (2012).
146. The FDCA provides that a cosmetic that Dcontains any poisonous or deleterious substance
which may render it injurious to users under the conditions of use prescribed in the [product’s]
labeling . . . or under such conditions of use as are customary or usual3 or that contains an Dunsafe3 color
additive as defined in FDCA § 721 (21 U.S.C. § 379e(a)) is adulterated, although it excepts coal-tar hair
dyes. FDCA §§ 301, 601, 21 U.S.C. §§ 331, 361 (2012). A cosmetic’s container can also render the
cosmetic adulterated if the Dcontainer is composed, in whole or in part, of any poisonous or deleterious
substance which may render the contents injurious to health.3 Id. Finally, the FDCA also provides that a
cosmetic that Dconsists in whole or in part of any filthy, putrid, or decomposed substance3 or that Dhas
been prepared, packed, or held under insanitary conditions whereby it may have become contaminated
with filth, or whereby it may have been rendered injurious to health,3 is adulterated. Id. In addition, the
FDCA provides that a cosmetic the labeling of which Dis false or misleading in any particular3 is
misbranded. FDCA § 602(a), 21 U.S.C. § 362(a); see also 21 C.F.R. § 1.21 (2018) (failure to reveal
material facts); 21 C.F.R. pt. 701 (2018) (Cosmetic Labeling). A cosmetic in packaged form the label of
which does not contain Dthe name and place of business of the manufacturer, packer, or distributor,3 Dan
accurate statement of the quantity3 of contents, or the required ingredient declarations is also misbranded.
FDCA § 602(b), 21 U.S.C. § 362(b); 15 U.S.C. § 1456 (2012); 21 C.F.R. § 701.3 (2018). Other
misbranding provisions address the prominence of required information, misleading containers, color
additives that don’t conform to packaging and labeling requirements, and violations of regulations issued
pursuant to the provisions of the Poison Prevention Packaging Act of 1980 regarding special packaging
standards for household substances to protect children from serious injury or illness and noncomplying
packages (21 U.S.C. §§ 1472-1473). FDCA § 601(c)-(f), 21 U.S.C. § 362(c)-(f) (2012). There are also
requirements for cosmetics under other laws. For example, under the Federal Trade Commission Act,
false, misleading, or deceptive advertising claims for cosmetics are prohibited. Federal Trade Commission
Act, 15 U.S.C. § 41-58; see also Jason Rea, “Actual Results May Vary”: Toward Fiercer National
Regulation of Digitally Manipulated Cosmetics Advertisements, 19 WM. & MARY J. WOMEN & L. 161,
163 (2012).
147. FDCA § 601(a), 21 U.S.C. § 361(a) (2012).
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The adulteration and misbranding provisions have been amended to reflect
the changes in how color additives are regulated: the adulteration provisions now
refer to unsafe color additives instead of uncertified coal-tar colors in the
provision providing that a cosmeticFother than a hair dyeFthat contains an
unsafe color additive is adulterated.148 The misbranding provisions also have
been amended to add a provision providing that a cosmetic that is a color additive
is misbranded if its packaging and labeling do not conform with the regulations
for that color additive.149 The misbranding provisions have also been amended
t, *r,'ide tCat a H,s.etiH is .isbranded D\i[f its *aHAaging ,r labeling is in
violation of an applicable regulation issued pursuant to [the Poison Prevention
Packaging Act (PPPA) (15 US.C. 1473-:>T[.3150 Also, intentionally added
plastic microbeads in wash-off cosmetics have been banned151 due to
environmental concerns about microbead pollution.152
b. FDA Regulations
Until 1972, FDA lacked a formal regulatory program for cosmetics, instead
taAing Dregulat,rW aHti,n ,n a case-by-Hase basis.3153 In the years since, FDA
has promulgated regulations specifically for cosmetics under the authority
granted to it by Congress under the FDCA, the PPPA, and the Fair Packaging &
Labeling Act.154 ManW ,f P_#’s H,s.etiHs regulati,ns set forth labeling
requirements.155 For example, cosmetics that are marketed to consumers are
required to have a list of ingredients,156 although there are exceptions for
fragrances and flavors, which may be listed as such.157
FDA has also restricted or prohibited the use of eleven ingredients or types
of ingredients in cosmetics due to safety concerns.158 It requires warnings on
148. FDCA § 601(e), 21 U.S.C. § 361(e) (2012).
149. FDCA § 602(e), 21 U.S.C § 362(e) (2012). Colors that Dare marketed and intended for use only
in or on hair dyes3 are excepted. Id.
150. FDCA § 602(f), 21 U.S.C § 362(f) (2012).
151. FDCA § 301(ddd), 21 U.S.C. § 331(ddd) (2017 supp. V).
152. See, e.g., Sarah Kettenmann, Nationwide Ban on Plastic Microbeads in Cosmetics, NAT.
RESOURCES&ENV’T, Summer 2016, at 58.
153. GAO, HRD-78-139, supra note 9, at iii.
154. See 21 C.F.R. pts. 700-740 (2018).
155. 21 C.F.R. § 701 (2018). There are also regulations related to the approval of color additives for
specific uses in cosmetics.
156. FDCA § 601, 21 U.S.C. § 361; 15 U.S.C. § 1456 (2012); 21 C.F.R. § 701.3; see also FDA
AUTHORITYOVERCOSMETICS, supra note 21 (noting tCat D\t[Cis re)uire.ent d,es n,t a**lW t, H,s.etiHs
distributed solely for professional use, institutional use (such as in schools or the workplace), or as free
sa.*les ,r C,tel a.enities3T. !,s.etiHs tCat d, n,t Ca'e tCe re)uired ingredient list are dee.ed
misbranded. See FDCA § 601, 21 U.S.C. § 361; 21 C.F.R. § 701.3 (2018).
157. FDCA § 602(a), 21 U.S.C. § 362(a); 21 C.F.R. § 701.3(a).
158. See 21 C.F.R. pt. 700 (2018); 21 C.F.R § 250.250 (2018) (Hexachlorophene, as a component of
drug and cosmetic products); see also Examining the Current State of Cosmetics: Hearing Before the
Subcomm. on Health, Comm. on Energy & Commerce, and H.R., 112 Cong. (2012) (statement of Michael
M. Landa, Director of Center for Food Safety & Applied Nutrition, Food & Drug Administration), https://
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certain cosmeticsFfeminine deodorant sprays, foaming detergent bath products,
coal tar hair dyes posing a risk of cancer, and sun tanning preparationsFas well
as cosmetics in self-pressurized containers and cosmetics containing an
ingredient tCat Cas n,t been Dade)uatelW substantiated f,r safetW.3159 In addition,
FDA has promulgated regulations that require tamper-resistant packaging for
certain cosmetics that are accessible to the public while held for retail sale.160
c. FDA Staff & Resources
Cosmetics are the only major product category that does not have its own
Henter ZitCin P_#% insteadS H,s.etiHs are regulated bW P_#’s !enter f,r P,,d
Safety and Applied Nutrition (CFSAN).161 /itCin tCe !PS#IS P_#’s 7ffiHe ,f
Cosmetics and Colors is responsible for both the oversight of cosmetics
regulation162 as well as the color additive certification program.163 In a 2008
report prepared by Peter Barton Hutt for the Science Review Subcommittee of
the FDA Science Board, he noted that FDA was unable to separate the funding
and personnel numbers for cosmetics from the numbers for CFSAN, a difficulty
that he indicated others had encountered as well.164 Nevertheless, Hutt
determined that between 1977 and 2007, funding and staff levels for cosmetics
regulation decreased to a total of fourteen staff at CFSANFwhich he described
as DHlearlW insuffiHient3Fand $3.5 millionFwhich he described as
D.ini.al.3165
archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Healt
h/20120327/HHRG-112-IF14-WState-LandaM-20120327.pdf [https://perma.cc/382A-ZWEL] [herein-
after Landa Statement]. These ingredients are bithionol, mercury compounds, vinyl chloride, certain
halogenated salicylanilides, zirconium, chloroform, methylene chloride, chlorofluorocarbon propellants,
certain cattle materials, sunscreens, and hexachlorophene. 21 C.F.R. pt. 700; 21 C.F.R. § 250.250
(Hexachlorophene, as a component of drug and cosmetic products). In contrast, the European Union,
which has taken a more stringent approach cosmetics, has Dbanned the sale of cosmetics or personal care
products that contain any ingredients on a list of more than one-thousand chemicals known or suspected
of causing cancer, genetic mutations, or birth defects.3 Deborah E. Mason, Kiss and Make-Up: A Need
for Consolidation of FDA and Cosmetic Industry Regulation Programs, 18 HEALTH MATRIX 181, 192
(2008).
159. 21 C.F.R. pt. 740 (2018).
160. 21 C.F.R. § 700.25 (2018).
161. FDA, About FDA, CFSAN&What We Do, https://www.fda.gov/AboutFDA/CentersOffices/Off
iceofFoods/CFSAN/WhatWeDo/default.htm [https://perma.cc/JJ67-FNLC] [hereinafter FDA, CFSAN];
Greff, supra note 27, at 248.
162. FDA STAFFMANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS, SMG 1231.141,
FOOD AND DRUG ADMINISTRATION, OFFICE OF FOODS AND VETERINARYMEDICINE, CENTER FOR FOOD
SAFETY AND APPLIED NUTRITION, OFFICE OF COSMETICS AND COLORS, DIVISION OF COLOR
CERTIFICATION AND TECHNOLOGY (Oct. 1, 2012), https://www.fda.Gov/Downloads/Aboutfda/Reports
manualsforms/Staffmanualguides/Ucm328610.Pdf [https://perma.cc/8QMY-WFQK].
163. Id.
164. Hutt, supra note 108, at 433.
165. Id. at 460-61. P_#’s ,*erating *lan f,r fisHal Wear ?Q@9S indiHates a t,tal ,f @@.: .illi,n d,llars
in budget authority funding for cosmetics activities (8.106 million for the center, 3.414 for the field, and
0.18 for the National Center for Toxicological Research). FDA, Food and Drug Administration,
Operating Plan for FY 2018, https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Rep
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d. Industry Measures
FDA relies heavily on voluntary industry measures for cosmetics.166 FDA
has created a voluntary registration program for cosmetics establishments.167 It
also has created a voluntary filing program for cosmetics ingredient composition
statements.168 These voluntary programs exclude cosmetics that are for
professional use only and those that are not for sale.169 The cosmetics industry
su**,rted tCese ',luntarW *r,gra.s as a ZaW Dt, de.,nstrate tCe industrW’s
willingness to supply information to FDA and to discourage Congressional
legislati,n.3170
The cosmetics industry has undertaken other voluntary measures. For
example, the Cosmetic Ingredient Review (CIR) reviews the safety of cosmetics
ingredients. TCe 6ers,nal !are 6r,duHts !,unHil U6!6!TS DtCe leading nati,nal
trade association representing the global cosmetic and personal care products
industrWS3 created and funds the review.171 As of March 2017, CIR had done
safety assessments of 4,740 ingredientsFD4,611 [were] determined to be safe as
used or safe with qualifications, 12 [were] determined to be unsafe, and 117
[were] ingredients for which the information is insufficient to determine
orts/BudgetReports/UCM610299.pdf [https://perma.cc/K7KV-LWY3]; see also FDA, FY 2018
Operating Plan Narrative, https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/
BudgetReports/UCM610298.pdf [https://perma.cc/67BT-VTHT].
166. For an analysis of how this compares with the regulation of other products, see Section II.C.2.e
below.
167. 21 C.F.R. §§ 710 & 720 (2018).
168. Id. §§ 710 & 720. FDA has also issued guidance regarding cosmetics. See, e.g., FDA, DRAFT
GUIDANCE FOR INDUSTRY: COSMETIC GOOD MANUFACTURING PRACTICES (June 2013),
https://www.fda.gov/cosmetics/guidanceregulation/guidancedocuments/ucm353046.htm
[https://perma.cc/T5D5-CUR4] [hereinafter FDA, COSMETIC GOOD MANUFACTURING PRACTICES];
FDA, GUIDANCE FOR INDUSTRY: SAFETY OF NANOMATERIALS IN COSMETIC PRODUCTS (June 2014),
https://www.fda.gov/downloads/Cosmetics/GuidanceRegulation/GuidanceDocuments/UCM300932.pdf
[https://perma.cc/R5WM-2MVS]; FDA, GUIDANCE FOR INDUSTRY, LEAD IN COSMETIC LIP PRODUCTS
AND EXTERNALLY APPLIED COSMETICS: RECOMMENDED MAXIMUM LEVEL DRAFT GUIDANCE (Dec.
2016), https://www.fda.gov/downloads/Cosmetics/GuidanceRegulation/GuidanceDocuments/UCM5172
68.pdf [https://perma.cc/EZ2V-X4JH] [hereinafter FDA: LEAD IN COSMETIC LIP PRODUCTS].
169. FDA, Voluntary Cosmetic Registration Program, https://www.fda.gov/cosmetics/registration
program/default.htm [https://perma.cc/N9VK-256L].
170. Personal Care Prods. Council, About Us: A Centennial History of the Personal Care Products
Council, https://www.personalcarecouncil.org/about-us/history?page=2 [https://perma.cc/9QWK-TCY
W].
171. Id.; Personal Care Prods. Council, https://www.personalcarecouncil.org [https://perma.cc/
2K9G-RNWZ]; Personal Care Products Council, CTFA Changes Name to the Personal Care Products
Council, Launches Consumer Information Web Site on Product Safety (Nov. 29, 2007),
https://www.personalcarecouncil.org/newsroom/ctfa-changes-name-personal-care-products-council-laun
ches-consumer-information-web-site-product-safe [https://perma.cc/S5WC-U7NV]; Casey Mee Lee
Daum, Self-Regulation in the Cosmetic Industry: A Necessary Reality or a Cosmetic Illusion? (May 2006)
(unpublished paper written to satisfy third-year writing requirement, Harvard Law School),
https://dash.harvard.edu/bitstream/handle/1/8965615/Daum06.html?sequence=2 [https://perma.cc/PV8H
-VPCD].
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safetW.3172 TCe !I4 is li.ited in tCat Dit generallW f,Huses ,n tCe ingredients’
potential to cause short-term dermatological reactions . . . not their potential to
cause long-ter. CealtC *r,ble.s.3173 Also, because the CIR is a voluntary
industry measure, companies are not required to follow it.174 It often finds
insuffiHient data t, Dsubstantiate safetW3175 and a significant amount of
information is not available to FDA and the public due to trade secret and
fragrance exceptions to public review.176
e. How Cosmetics Law & Regulation Lag Behind that of Other
Product Categories
While the FDCA has been amended to give FDA greater authority over the
other major product categories under its jurisdiction and strengthen its regulation
of those product categories, as discussed above, the cosmetics provisions have
remained largely unchanged. Accordingly, cosmetics are the least regulated of
the major product Hateg,ries ZitCin tCe P,,d and _rug #d.inistrati,n’s UP_#T
jurisdiction.177 This Section highlights some of the ways cosmetics law and
regulation are less stringent than the law and regulation for other product
categories.
As discussed in Section II.B, even if cosmetics are the safest product
category, they are not necessarily safe. The shortcomings of current cosmetics
law and regulation are particularly problematic because they hinder the ability to
172. Ivan J. Boyer et al., The Cosmetic Ingredient Review Program&Expert Safety Assessments of
Cosmetic Ingredients in an Open Forum, 36 INT’L J. TOXICOLOGY (SUPPLEMENT 2) 5S, abstract (2017).
For a discussion of the number of cosmetics ingredients, see infra notes 186G195 and accompanying text.
The Research Institute for Fragrance Material, another self-regulatory program, reviews fragrance safety.
Caroline M. Reebs, Fragrant or Foul? Regulation of the Global Perfume Industry and the Implications
for American Sovereignty, 34 HASTINGS INT’L&COMP. L. REV. 223, 237 (2011) (discussing critiques of
the expert panel which reviews fragrance safety data). But see Thomas J. Donegan, Jr., Fifty Years of
Cosmetic Safety: A Government and Industry Partnership, 50 FOOD&DRUGL.J 151, 156 (1995) (arguing
that D[t]he CIR and RIFM programs combined are very effective in protecting public safety and in
anticipating problems before government action is necessary3).
173. Shah & Taylor, supra note 99, at 204; Envtl. Working Group (EWG), FDA Fails to Protect
Consumers (2005), https://www.ewg.org/skindeep/2005/10/05/fda-fails-to-protect-consumers/#.W2sDii
_GzGJ [https://perma.cc/XWK2-YL4L] [hereinafter EWG, FDA Fails to Protect]; see also ALEXANDER
SCRANTON, WOMEN’S VOICES FOR THE EARTH, COSMETIC INGREDIENT REVIEW: FAILING THE PUBLIC.
FAILINGMANUFACTURERS. AN INVESTIGATIVEBRIEF BYWOMEN’SVOICES FOR THEEARTH (Apr. 2018),
https://www.womensvoices.org/wpcontent/uploads/2018/04/CIR_final_report.pdf [https://perma.cc/T76
D-P6H5] (arguing that Dthe CIR has significantly underestimated or dismissed potential health and
environmental hazards of cosmetic ingredients3).
174. See Boyer et al., supra note 172, at 5S; Sarah E. Schaffer, Reading Our Lips: The History of
Lipstick Regulation in Western Seats of Power, 62 FOOD&DRUG L.J. 165, 200 (2007).
175. Hartman, supra note 110, at 64; EWG, FDA Fails to Protect, supra note 173.
176. Shah & Taylor, supra note 99, at 226.
177. Paradise & Fitzpatrick, supra note 9, at 70; see also GAO/HRD-90-58, supra note 9;
STATEMENT OFGREGORY J. AHART, supra note 9; GAO, HRD-78-139, supra note 9; see also supra note
161 and accompanying text (noting that cosmetics are the only major product category that does not have
its own center devoted to their regulation).
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accurately assess the safety of cosmetics, which in turn hinders the development
of an appropriate regulatory system for cosmetics, leaving consumers at risk.
While drug, device, and tobacco product establishments and food facilities
must register with FDA,178 FDA has no mandatory registration requirement for
cosmetics.179 Instead, P_#’s registrati,n *r,gra. f,r H,nsu.er H,s.etiHs
products is voluntary.180 #s a resultS P_# .aW n,t DAn,Z tCe nu.ber ,f
.anufaHturersS ZC, tCeW areS ZCere tCeW areS and ZCat tCeW .aAe.3181 Since the
Voluntary Cosmetics Registration Program was established in 1972, there have
been 3,260 active cosmetics establishment registrations,182 but because
registration is voluntary and only covers products marketed to consumers, this
d,es n,t re*resent DtCe t,tal nu.ber ,f companies manufacturing or marketing
H,s.etiHs in tCis H,untrW.3183
Import and industry data suggest that the number of cosmetics
establishments eligible for registration may be much higher than the number who
have registered. Based on import records, FDA estimates that there are 29,000
foreign companies that manufacture cosmetics for or export cosmetics to the
United States,184 and IBISWorld estimates that there are 4,055 cosmetics and
beauty product manufacturers in the United States.185
Furthermore, unlike drug registrants, which are required to list with FDA
drugs for commercial distribution and provide the name of each ingredient,186
cosmetics manufacturers are not required to report the ingredients in their
cosmetics *r,duHts t, P_#. P_# Desti.ate\s[ tCat ,nly one-third of cosmetics
178. See FDCA § 510(g), 21 U.S.C. § 360; FDCA § 415, 21 U.S.C. § 350d; FDCA § 905, 21 U.S.C.
§ 387e; 21 C.F.R. pt. 807 (2018); 21 C.F.R. pt. 1, subch. H (2018); 21 C.F.R. pt. 207 (2018).
179. See FDA, Voluntary Cosmetic Registration Program, supra note 169; Landa Statement, supra
note 158, at 4G5, 9; COHEN, supra note 2, at 35.
180. FDA, Voluntary Cosmetic Registration Program, supra note 169; see also Landa Statement,
supra note 158, 4-5; COHEN, supra note 2, at 35.
181. FDA, Adverse Event Reports, supra note 10.
182. FDA, Registration Reports, https://www.fda.gov/Cosmetics/RegistrationProgram/Registration
Reports/default.htm [https://perma.cc/CR62-8CXH]; see also Landa Statement, supra note 158 (stating
that in 2012 the Voluntary Cosmetics Registration Program Dha[d] almost 1,600 domestic and foreign
registered cosmetics establishments3).
183. FDA, Registration Reports, supra note 182; FDA, Voluntary Cosmetic Registration Program,
supra note 169 (DAbout VCRP3).
184. Letter from Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation &
Analysis, U.S. Food & Drug Admin., to the Honorable Frank Pallone, Jr., Ranking Member, Committee
on Energy & Commerce, House of Representatives 2 (June 30, 2017), https://democrats-energycom
merce.house.gov/sites/democrats.energycommerce.house.gov/files/documents/FDA%20Response%20to
%20Rep.%20Pallone%20on%20Cosmetic%20Imports.pdf [https://perma.cc/GK4Z-XKFR].
185. COHEN, supra note 2, at 4; see also supra Section I.A (discussing definition of cosmetics).
186. FDCA § 510, 21 U.S.C. § 360 (2018 supp. V); Who must list drugs and what drugs must they
list?, 21 C.F.R. § 207.41 (2018); What listing information must a registrant submit for a drug it
manufactures?, 21 C.F.R. § 207.49 (2018); see also FDCA § 904(a)(1), 21 U.S.C. § 387d (2012); FDA,
Submit Ingredient Listing for Tobacco Products, https://www.fda.gov/TobaccoProducts/Guidance
ComplianceRegulatoryInformation/Manufacturing/ucm602792.htm#9 [https://perma.cc/RK3G-FV62].
While food manufacturers generally do not need to notify or otherwise inform FDA of all of the
ingredients that they use in food, this has been the subject of significant critique. See, e.g., Martha Dragich,
GRAS-Fed Americans: Sick of Lax Regulation of Food Additives, 49 IND. L. REV. 305, 311 (2016).
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.anufaHturers ',luntarilW file ingredient state.ents f,r tCeir *r,duHts3 tCr,ugC
the Voluntary Cosmetic Registration Program,187 which, as noted above, only
includes consumer cosmetics.188 And unlike drugs and foods, which are
generally required to have ingredient labeling regardless of whether the product
is intended for consumer or professional use,189 only cosmetics intended for retail
sale are required to have ingredient labeling under the Fair Packaging and
Labeling Act (FLPA) and FD#’s regulati,ns.190 Cosmetics intended for
professional use only are not required to have ingredient labeling.191
Accordingly, both the identity and number of ingredients used in cosmetics is
unknown. And consumers and workers may be unaware that the cosmetic
intended for professional use only contains a potentially harmful ingredient.192
The number of ingredients used in cosmetics is likely higher than the number
of ingredients voluntarily reported by the cosmetics industry.193 The number of
ingredients that the industry has submitted to the Voluntary Cosmetic
Registration Program and the number of ingredients in the International
Cosmetic Ingredient Dictionary, however, may give some indication of the
number of ingredients used in cosmetics. The industry has submitted about
D;SQQQ ingredients used in 9@ *r,duHt Hateg,ries3 t, tCe V,luntarW !,s.etiH
Registration Program.194 The International Cosmetic Ingredient Dictionary and
Nandb,,A Dlists ,'er ?@SQQQ indi'idual ingredients tCat were once used, are
HurrentlW usedS ,r are .erelW a su**lier’s C,*e f,r future useS3 and ,ne re'ieZ
,f tCe !I4 *r,Hess esti.ates tCat ab,ut D>Q- .aW be eXHluded fr,. . . . re'ieZ3
and ab,ut D>?- are HurrentlW in use.3195 FDA estimated at one point that there
Zere D\a[b,ut @?S<QQ different H,s.etiH ingredients and a si.ilar nu.ber ,f
fragrance ingredients . . . being used bW tCe H,s.etiH industrW.3196
Concerns about cosmetics manufacturers failing to voluntarily register their
establishments and products and file ingredient statements are not new. In a 1978
report, the United States General Accounting Office (GAO) recommended that
187. Landa Statement, supra note 158.
188. See supra note 180 and accompanying text.
189. FDCA § 403(i), (q), 21 U.S.C. § 343(i), (q) (2012); FDCA § 502(e), 21 U.S.C. § 352(e) (2012).
190. See FDCA, Fair Packaging and Labeling Act (FLPA), Pub. L. No. 89-755, 80 Stat. 1296 (1966)
(codified at 15 U.S.C. §§ 1451G1461 (1970)); 21 C.F.R. § 701.3 (2018).
191. See AMALIA K. CORBY-EDWARDS, ANALYST IN PUB. HEALTH & EPIDEMIOLOGY, CONG.
RESEARCH SERVICE, R42594, FDA REGULATION OF COSMETICS AND PERSONAL CARE PRODUCTS (July
9, 2012), http://asbcouncil.org/sites/default/files/library/docs/crs_report_fda_regulation_of_cosmetics_
and_personal_care_products.pdf [https://perma.cc/9SY8-XJBR].
192. See, e.g., Sharon E. Jacob et al., Commentary, p-Phenylenediamine in Black Henna Tattoos: A
Practice in Need of Policy in Children, ARCHIVES OF PEDIATRICS&ADOLESCENTMED. 790, 791 (2008).
193. See Boyer et al., supra note 172.
194. Id. at 7S.
195. Id. at 7S, 10S.
196. FDA, COMPLIANCE PROGRAM GUIDANCE MANUAL, PROGRAM 7329.001 ch. 29 (Sept. 30,
2008), https://web.archive.org/web/20090528173701/http://www.cfsan.fda.gov/~acrobat/cp29001.pdf
[https://perma.cc/PSL7-UDHU].
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Congress give FDA the authority to require cosmetics establishment and product
registration and the filing of ingredient statements.197
The infrequency of cosmetics establishment inspections is also cause for
concern. While the frequency of inspection for food, drug, device, and tobacco
product establishments is specified by law, there are no comparable requirements
for cosmetics establishments.198 For example, the FDCA provides that domestic
food facilities must be inspected, depending on their risk classification, once
every three or five years.199 The FDCA has also directed FDA to inspect drug
and device establishments according to a risk-based schedule established by
regulation.200
Given the lack of statutory mandate for cosmetics establishment inspection
and tCe P_#’s li.ited res,urHesS it is n,t sur*rising tCat H,s.etiHs
establishments are inspected infrequently. In 2016, FDA inspected a total of 136
cosmetics establishmentsF133 domestic and 3 foreign.201 The lack of required
establishment registration may also complicate inspection efforts, as FDA may
be unaware of some cosmetics establishments.202 The low inspection rate for
cosmetics establish.ents is n,t neZ. In @8:9S P_#’s !,s.etiHs _ireHt,r n,ted
tCat D\a[t P_#’s fisHal @8:8 le'elsS a H,s.etiH *lant Z,uld be ins*eHted ZitC,ut
s*eHial HirHu.stanHes e'erW ?Q t, ?< Wears.3203
PurtCer.,reS tCe sH,*e ,f P_#’s ins*eHti,n autC,ritW f,r H,s.etiHs is
limited compared to drugs, certain devices, tobacco products, and foods. For
example, if FDA has a reasonable belief that a food is adulterated and presents a
threat of serious adverse health consequences or death, it may access records
related to the food.204 FDA may also inspect records bearing on whether
Dprescription drugs, nonprescription drugs intended for human use, restricted
de'iHesS ,r t,baHH, *r,duHts3 are adulterated.205
197. See GAO, HRD-78-139, supra note 9, at 133.
198. See FDCA § 510(h), 21 U.S.C. § 360(h); FDCA § 421, 21 U.S.C. § 350j; FDCA § 905(g), 21
U.S.C. § 387e(g).
199. FDCA § 421, 21 U.S.C. § 350j.
200. FDCA § 510, 21 U.S.C. § 360(h).
201. FDA, OFFICE OF REGULATORY AFFAIRSFFIELD ACTIVITIES, FY 2018 FOODS (2018),
https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM56633
1.pdf [https://perma.cc/YHC6-7U9A].
202. See GAO, HRD-78-139, supra note 9; see also GAO, HRD-78-139, supra note 9, at v (stating
that in the mid-1970s FDA Didentified about 1,000 additional manufacturers, which it had never inspected
because they had been unknown to the agency3).
203. 2 JAMES T. O’REILLY & KATHARINE A. VAN TASSELL, FOOD AND DRUG ADMINISTRATION
§ 17:9 (2018) (citing Address by Eiermann, FDA Cosmetics Director, to Society of Cosmetics Chemists
(Sept. 27, 1978)).
204. FDCA § 704, 21 U.S.C. § 374; FDCA § 414, 21 U.S.C. § 350c(a)(1); see also FDA, GUIDANCE
FOR INDUSTRY, FDA RECORDS ACCESS AUTHORITY UNDER SECTIONS 414 AND 704 OF THE FEDERAL
FOOD, DRUG, AND COSMETIC ACT (Apr. 2014), https://www.fda.gov/Food/GuidanceRegulation/ucm292
745.htm [https://perma.cc/NW4J-B94Y].
205. FDCA § 704, 21 U.S.C. § 374.
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In H,ntrastS P_#’s ins*eHti,n autC,ritW f,r H,s.etiHs is generallW restriHted
to certain establishments and vehicles and does not extend to records.206
Accordingly, manufacturers DCa'e refused Food and Drug Administration
ins*eHt,rs aHHess t, .anufaHturing reH,rds.3207 This may prevent FDA from, for
eXa.*leS effeHti'elW enf,rHing its re)uire.ent DtCat labeling ,f H,s.etiHs tCat
Ca'e n,t been ade)uatelW tested f,r safetW inHluding a Zarning t, tCat effeHtS3 as
tCe laZ d,esn’t re)uire tCat .anufaHturers D.aAe tCeir test results available to
tCe agenHW.3208 TCis .aW als, li.it P_#’s abilitW t, in'estigate safetW issues
potentially associated with cosmetics.209
While FDA has promulgated quality systems regulations, known as Current
Good Manufacturing Practice regulations, for foods,210 drugs,211 and devices,212
it has only issued non-binding draft guidance and guidelines for cosmetics.213
TCis .aW Cinder P_#’s abilitW t, ade)uatelW regulate H,s.etiHs as O,,d
ManufaHturing 6raHtiHe regulati,nsZ,uld *r,'ide DHriteria t, deter.ineZCetCer
adequate methods, facilities, and controls are used in all phases of manufacturing
and distributi,n ,f H,s.etiHs.3214
The lack of mandatory reporting of adverse events to FDA is another area
where cosmetics lag behind. While dietary supplement, drug, and device
manufacturers must report certain adverse events215 and food manufacturers
must report reportable foods,216 there are no comparable mandatory requirements
for cosmetics.217 FDA relies on voluntary measures for cosmetics.218 Without
206. Id.
207. GAO, HRD-78-139, supra note 9, at iii.
208. Id.
209. FDA, FDA Information for Consumers About WEN by Chaz Dean Cleansing Conditioners,
https://www.fda.gov/cosmetics/productsingredients/products/ucm511631.htm [https://perma.cc/JW68-F
7RF] [hereinafter FDA, Information About WEN].
210. 21 C.F.R. pts. 110, 111 (2018).
211. 21 C.F.R. pts. 210, 211, 225, 226 (2018).
212. 21 C.F.R. pt. 820 (2018).
213. FDA, COSMETICGOODMANUFACTURING PRACTICES, supra note 168; Landa Statement, supra
note 158; see also Greff, supra note 27, at 246. The FDCA requires FDA to promulgate regulations
regarding tobacco product manufacturing practice regulations. See FDCA § 906, 21 U.S.C. § 387f(e); see
also FDA, Tobacco Product Manufacturing Practice; Request for Comments, 82 Fed. Reg. 55,613 (Nov.
22, 2017).
214. GAO, HRD-78-139, supra note 9, at v.
215. FDCA § 201(ff), 21 U.S.C. § 321(ff); FDCA § 761, 21 U.S.C. § 379aa-1 (dietary supplements);
FDCA § 760, 21 U.S.C. § 379aa (nonprescription drugs); FDCA § 761(a)(1), 21 U.S.C. § 379aa-1(a)(1);
21 C.F.R. § 314.80 (drugs) (2018); 21 C.F.R. § 803 (medical devices) (2018); see also FDA, Mandatory
Reporting Requirements: Manufacturers, Importers and Device User Facilities, https://www.fda.gov/
medicaldevices/deviceregulationandguidance/postmarketrequirements/reportingadverseevents/default.ht
m [https://perma.cc/AHE5-2P39].
216. FDCA § 417, 21 U.S.C. § 350f.
217. See FDA, Adverse Event Reports, supra note 10.
218. Daum, supra note 171. CFSAN has an adverse event report system where consumers,
manufacturers, and health care professionals can voluntarily report adverse events associated with
regulated products including cosmetics. See FDA, Adverse Event Reports, supra note 10; Michael Kwa
et al., Research Letter, Adverse Events Reported to the US Food and Drug Administration for Cosmetics
and Personal Care Products, Research Letter, 177 JAMA INTERNALMED. 1202 (Aug. 2017).
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mandatory reporting for cosmetiHsS as tCe_ireHt,r ,f P_#’s7ffiHe ,f!,s.etiHs
and !,l,rs reHentlW stated in an inter'ieZS D,ften . . . [FDA is] just seeing the tip
,f tCe iHeberg in \tCe ad'erse e'ent re*,rting sWste.[.3219 For example, as of
November 15, 2016, FDA had received 1,386 H,nsu.er Dre*,rts ,f reaHti,ns
re*,rted t, be ass,Hiated ZitC3 Hertain H,s.etiHs cleansing conditioners:220
D/Cen . . . FDA inspected the manufacturing and distribution facilities for these
products, [it] learned that consumers had reported reactions in more than 21,000
complaints submitted to . . . the companies that market and manufacture the
products.3221 Under the current law, the companies are not required to report
these complaints.222 At one point, FDA had regulations for a voluntary program
for the filing of cosmetics product experiences by cosmetics manufacturers, but
these regulations were revoked.223
Finally, cosmetics do not require FDA approval prior to sale.224 In every
other major product category included in the 1938 FDCA, at least some products
now must be approved before they can be lawfully sold.225 Under the FDCA, the
policing of the adulteration and misbranding of Dcosmetics3 as a category takes
place after a violation occurs.226 And in a judicial action to enforce the Act, the
burden is on the government to prove that the product is adulterated or
misbranded,227 rather than on the manufacturer to show that it is safe.228
219. FDA, Adverse Event Reports, supra note 10.
220. FDA, Information About WEN, supra note 209.
221. Id.
222. Id.
223. See 21 C.F.R. § 730 (1997) (Voluntary Filing of Cosmetic Product Experiences); FDA, Food
and Cosmetic Labeling; Revocation of Certain Regulations, 62 Fed. Reg. 43,071, 43,073 (revoking 21
C.F.R. pt. 730); FDA, Adverse Event Reports, supra note 10. In the notice proposing to revoke the
Voluntary Cosmetic Reporting Program regulations, FDA noted that the program suffered from Dserious
limitations3: industry participation was Dvery limited and selective, the reports lack[ed] sufficient details
to be useful, and annual reports are sent in long after the occurrence of an adverse reaction.3 FDA, Food
and Cosmetic Labeling; Revocation of Certain Regulations; Opportunity for Comment, 61 Fed. Reg.
29,708, 29,710 (June 12, 1996) (proposed rule). FDA also noted its Dbudgetary constraints.3 Id.
224. See FDA, Voluntary Cosmetic Registration Program, supra note 169.
225. See FDCA § 409, 21 U.S.C. § 348 (food additives); FDCA § 505, 21 U.S.C. § 355 (new drugs);
FDCA §§ 513, 515, 21 U.S.C. §§ 360c(a), 360e (class III devices). As noted earlier, Dcolor additives3
have to be approved for a particular use before being so used. See supra note 22.
226. See FDCA §§ 301, 601, 602, 21 U.S.C §§ 331, 361, 362 (2012); see also GAO, HRD-78-139,
supra note 9 (stating that Da hazardous cosmetic can be marketed until the [FDA] obtains information to
prove that the product may be injurious to users3); Letter from Art O. Czabaniuk, Dist. Director, Detroit
Dist. Office, U.S. Food & Drug Admin., to Ms. Kathie De Voe, President & Chief Executive Office,
Gilchrist & Soames, Inc., Warning Letter 2016-DET-09 (Mar. 16, 2016), https://www.fda.gov/ICECI/
EnforcementActions/WarningLetters/2016/ucm491990.htm [https://perma.cc/4HQC-PRA5]; Letter from
Alonza E. Cruse, Director, Los Angeles Dist., U.S. Food & Drug Admin., to Patricia Alvarez, President,
Gemdo Cosmetics Inc., Warning Letter WL-16-15 (Apr. 16, 2015), https://www.fda.gov/ICECI/
EnforcementActions/WarningLetters/2015/ucm443701.htm [https://perma.cc/LQY9-83TM].
227. FDCA §§ 301, 601, 602, 21 U.S.C §§ 331, 361, 362.
228. See, e.g., GAO, HRD-78-139, supra note 9.
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III. GENDER, FEMINISM&COSMETICS LAW&REGULATION
This Part argues that cosmetics law and regulation have been deprioritized
as a result of their longstanding and close association with femininity and
Z,.enS and Z,.en’s eXHlusi,n fr,. *,litiHal *artiHi*ati,n and re*resentati,n.
The 1906 Pure Food and Drugs Act did not explicitly address cosmetics. While
the 1938 Federal Food, Drug and Cosmetic Act did, women were excluded from
full participation during the consideration of both Acts, and consideration of the
later Act was marred by the biases of some of the male participants. This Part
also argues that cosmetics law and regulation have been deprioritized as a result
of their longstanding and close association with women and femininity, which
have often been devalued. Finally, this Part argues that cosmetics law and
regulation have been deprioritized as a result of debate among self-described
fe.inists regarding tCe .eaning ,f H,s.etiHs and differenHes in Z,.en’s
relationships to and views of cosmetics more generally.
A. Cosmetics Law & Regulation Have Been Deprioritized as a Result of
Women’s *)clusion from Political Participation & Representation, as well
as their Longstanding & Close Association with Femininity & Women
The Pure Food & Drugs Act of 1906
The Pure Food and Drugs Act of 1906 did not regulate cosmetics.229
Historian Gwen Kay describes the omission of cosmetics from the 1906 act as
an economic and political decision.230 /Cile earlier bills defined Ddrug3 t,
inHlude DH,s.etiHsS3231 in 1900, cosmetics were dropped from the legislation,
apparently in exchange for the support of the National Pure Food and Drug
Congress.232 At that time, the cosmetics industrW’s sH,*e Zas li.ited: tCe @988
.anufaHturing Hensus *ut tCe 'alue ,f D*erfu.erW and H,s.etiH3 industrW
229. See Federal Food & Drugs Act, 34 Stat. 768 (June 30, 1906) [hereinafter Pure Food and Drugs
Act].
230. KAY, supra note 3, at 30.
231. See, e.g., S. 4144, 55th Cong. (1898); H.R. 9154, 55th Cong. (1898).
232. Oscar E. Anderson, Jr., Pioneer Statute: The Pure Food and Drugs Act of 1906, 13 J. PUB. L.
189, 195 (1964); CHARLESO. JACKSON, FOODANDDRUGLEGISLATION IN THENEWDEAL 4 (1970); KAY,
supra note 3, at 15. The National Pure Food and Drug Congress was convened to support a food and drug
law and was to be comprised of delegates Dembrac[ing] as far as possible every interest involved in the
production, manufacturer, and sale of food, drugs and liquor products,3 as well as DScientists and Health
Departments,3 and Dthose who have charge of local laws in the various States and Territories.3 1898 J.
PROC. OF THENAT’L PURE FOOD&DRUG CONGRESS 4, https://ia801404.us.archive.org/21/items/journal
proceedi00unkngoog/journalproceedi00unkngoog.pdf. Proposed language from the 1898 proceedings of
the National Pure Food and Drug Congress included cosmetics within the definition of drug. Id. at 36.
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products at about seven million dollars, and in 1904 the value was about eleven
million dollars.233
GenderFas well as race, ethnicity, and classFlikely contributed to the
failure of Congress to include cosmetics in the 1906 Pure Food and Drugs Act.
Unlike food and drugsFwhich had problems that generated broad public outrage
and which were included in the 1906 Pure Food and Drugs Act234Fcosmetics,
while not without their hazards,235 DZere eXtre.elW easW t, ,'erl,,A.3236 The
industry was relatively small,237 and H,s.etiHs Zere D*urHCased and H,nsu.ed
by only half the population3: Z,.en.238 In addition, many women made their
own cosmetics at home.239 Even among women who used what today would be
H,nsidered H,s.etiHsS .anW .aW Ca'e s,ugCt t, Cide tCis use as D\a[.,ng ZCite
women . . . popular concern centered on the morality of visible .aAeu*S3 ZCiHC
Zas Dass,Hiated ZitC *r,stitutes and aHtresses.3240 IndeedS tCe D\Z[,.en
applying dangerous lead-based whitening lotions . . . [who] began to appear in
medical case records after the Civil War . . . [went] to great lengths to conceal
their c,s.etiHs use.3241
The use and advertising of cosmetics also reflected racial and ethnic
tensions, including white concerns about maintaining existing racial
hierarchies.242#t tCe ti.eS DtCe standard ,f beautW inCerentlW assu.ed a n,rtCern
Eur,*ean faHe.3243 Skin whitenersFwhich were marketed to both white and
black womenFDremained the most popular cosmetic throughout the nineteenth
HenturW.3244 !,s.etiHs Dreinf,rHed a n,Xi,us raHial aestCetiHS3 in ZCiHC
D\n[,ti,ns ,f #ngl,-American beauty . . . were continually asserted in relation
233. U.S. DEP’T OF COMMERCE, BUREAU OF THE CENSUS, BIENNIAL CENSUS OF MANUFACTURES
1921, at 745, 746 tbl.623 (1924) [https://perma.cc/2HBQ-NCVA] [hereinafter 1921 MANUFACTURES
CENSUS] (DPerfumery and cosmetics include perfumes, toilet waters, toilet preparations, cold cream, face
powders, etc.3) (ebook).
234. Pure Food and Drugs Act, supra note 229. See, e.g., KAY, supra note 3, 17-22; Jeffrey E.
Shuren, The Modern Regulatory Administrative State: A Response to Changing Circumstances, 38 HARV.
J. ON LEGIS. 291, 299 (2001); Kara W. Swanson, Food and Drug Law as Intellectual Property Law:
Historical Reflections, 2011 WIS. L. REV. 331, 337.
235. See, e.g., PEISS, supra note 3, at 41-42.
236. KAY, supra note 3, at 30.
237. See supra note 68 and accompanying text.
238. KAY, supra note 3, at 30.
239. Id. at 10G12.
240. Id. at 32G33; PEISS, supra note 3, at 7.
241. PEISS, supra note 3, at 41.
242. Id. at 40G43.
243. KAY, supra note 3, at 31.
244. PEISS, supra note 3, at 40.
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t, *e,*le ,f H,l,r3245 and D\s[Ain ZCiteners and Cair straigCteners Zere t,Aens
in a Ceated debate3 ab,ut beautW standards among black women.246
/Cile Z,.en’s ,rganiVati,ns *laWed an i.*,rtant r,le in tCe enaHt.ent ,f
the 1906 Pure Food and Drugs Act,247 cosmetics do not appear to have been a
Hentral f,Hus ,f .anW ,f tCese gr,u*s. TCis .aW Ca'e been beHause D\t[Ce
women who belonged to many of these groups, upper-class and white, would
.,st liAelW n,t Ca'e Z,rn U'isibleT H,s.etiHs at tCe beginning ,f tCe HenturW3248
beHause DZ,.en ZC, 'isiblW Z,re H,s.etiHs in tCe last tCird ,f tCe nineteentC
century were [considered] morally sus*eHt and liable t, HritiHis..3249 These
gr,u*s .aW Ca'e DunH,nsHi,uslW a**lied .iddle- and upper-class morals and
s,luti,ns t, tCe f,,d and drug *r,ble..3250 Indeed, one history of the push for
pure food and drug laws, which focuses on the role of women, makes scant
mention of cosmetics, noting only in passing that in 1898, a proposed definition
,f Ddrug3 inHluded H,s.etiHsS and tCat in @8Q< tCe Iati,nal !,nsu.ers’
Jeagues’ 6ure P,,d !,..ittee inHluded in tCeir g,als tCat DagenHies sC,uld
ensure cosmetics were safe and *r,*erlW labeled.3251But because cosmetics were
inHluded ZitCin tCe *r,*,sed definiti,n ,f drugs until @8QQS it’s difficult to
distinguish early general support for drug legislation from support for cosmetic
legislation.252
/,.en’s laHA ,f re*resentation in the legislative process during the
consideration and passage of the 1906 Pure Food and Drugs Act may have also
contributed to the exclusion of cosmetics, as women did not have the right to
vote nationwide until approximately 14 years after the Act was signed into
law.253 When the Pure Food and Drugs Act passed in 1906, no woman had ever
served in the United States House of Representatives or Senate.254 It would be
245. Id. at 31, 34 (stating that D[f]or white Americans, sustaining a visual distinction between white
and black masked an uncomfortable truth, that Africans and Europeans were genealogically mixed3 and
D[i]n advice manuals and formula books, white fears of losing their superior racial identity underwrote
old anxieties about cosmetic artifice3).
246. See, e.g., id. at 7; NOLIWE M. ROOKS, HAIR RAISING: BEAUTY, CULTURE, AND AFRICAN
AMERICANWOMEN 37 (1996).
247. See, e.g., KAY, supra note 3; James Harvey Young, The Government and the Consumer:
Evolution of Food and Drugs Laws, The 1938 Food, Drug, and Cosmetic Act, 13 J. PUB. L. 197, 199
(1964).
248. KAY, supra note 3, at 15, 17.
249. Id. at 31.
250. Id. at 15, 17.
251. LORINE SWAINSTON GOODWIN, THE PURE FOOD, DRINK, AND DRUG CRUSADERS, 1879-1914,
at 114, 161 (1999).
252. See Anderson, supra note 232, at 195.
253. U.S. CONST. amend. XIX.
254. JENNIFER E. MANNING & IDA A. BRUDNICK, CONG. RESEARCH SERV., RL30261, WOMEN IN
CONGRESS, 1917-2018: SERVICE DATES AND COMMITTEE ASSIGNMENTS BY MEMBER, AND LISTS BY
STATE AND CONGRESS (2018), https://fas.org/sgp/crs/misc/RL30261.pdf [https://perma.cc/VMN3-
KBQN]. The lack of diversity was not limited to gender. There were also no African American, Asian
American, Native American, or Hispanic American senators. Ethnic Diversity in the Senate, UNITED
STATES SENATE, https://www.senate.gov/senators/EthnicDiversityintheSenate.htm [https://perma.cc/XZ
K9-AEN8]. The Asian Americans and Hispanic Americans in the House of Representatives were all non-
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over a decade until the first woman served in the House and even longer until a
woman served in the Senate.255 As one commentator noted, DtCe undeniable
realitW ,f Z,.en’s *,litiHal i.*,tenHe in @8Q; surelW H,nstituted a .aB,r faHt,r
in tCe eXHlusi,n ,f H,s.etiHs fr,. tCe @8Q; #Ht.3256
The Federal Food, Drug & Cosmetic Act of 1938
While a comprehensive examination of the history of the cosmetics
provisions of the 1938 FDCA is beyond the scope of this Article, portions of that
history provide examples of how gender shaped consideration of bills to
strengthen the law. Between the enactment of the Pure Food and Drugs Act of
1906 and the passage of the 1938 FDCA, it became more socially acceptable for
women to use cosmetics, and the cosmetics industry grew substantially. At the
same time, a number of women were seriously injured by cosmetics that federal
law was powerless to address and there were growing concerns about the safety
of cosmetics. The history of cosmetics and the development of cosmetics law
during the period preceding the 1906 Pure Food and Drugs Act through the
enactment of the 1938 FDCA illustrates the gendered roots of cosmetics law.257
This history is particularly important because this law has changed little in the
intervening eighty years. The 1938 Act, with few modifications, remains the
basis of cosmetics law and regulation, and women still fall far short of equal
representation in the United States Senate and House of Representatives.258
a. Cosmetics Growth & Change, 1906-1938
In the years after the enactment of the 1906 Pure Food and Drugs Act, the
cosmetics industry grew rapidly.259 "W @8?QS tCe t,ilet g,,ds industrW Zas D,ne
of the largest . . . in the United States, behind food, clothing, and
aut,.,biles.3260 In 1933, the U.S. Census Bureau reported that the value of
voting delegates or resident commissioners from Hawaii and Puerto Rico. HISTORY, ART & ARCHIVES:
UNITED STATESHOUSE OFREPRESENTATIVES, http://history.house.gov/People/Search/ [https://perma.cc/
HCD7-S4UA] (search by categories and by congress).
255. MANNING&BRUDNICK, supra note 254.
256. Daum, supra note 171.
257. The Author plans to more fully examine legislative history of the cosmetics provisions of the
FDCA and the role of women in future scholarship.
258. Darla Cameron & Kim Soffen, For Every Woman in Political Office in South Carolina, There
Are Six Men, WASH. POST (Feb. 7, 2018), https://www.washingtonpost.com/graphics/2018/politics/
women-running-for-office/?utm_term=.d24fb48a3a96 [https://perma.cc/3M8H-JS7J] (stating that 22 out
of 100 Senators and 84 out of 432 House members are women).
259. See 1921MANUFACTURESCENSUS, supra note 233, at 745, 746 tbl.623; see alsoGILBERTVAIL,
A HISTORY OFCOSMETICS INAMERICA 137 (1947) (listing statistics from the reports of the United States
Census Bureau). In 1929, the value of the industry was approximately $193 million. It then declined to
$153 million in 1931. VAIL, supra, at 137.
260. KAY, supra note 3, at 39.
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cosmetics industry production was about 97 million dollars.261 That same year
Senator Royal S. Copeland introduced a bill, S. 1944, to strengthen the 1906
Pure Food and Drugs Act,262 by, among other things, extending the Act to
prohibit the adulteration, misbranding, and false advertisement of cosmetics.
During a hearing on the bill in December of 1933, the Secretary of Agriculture
testified tCat D\t[Ce H,s.etiH industrW Ca\d[ beH,.e ,f first i.*,rtanHeS3 ZCereas
it Cad been Din its infanHW3 ZCen tCe @8Q; #HtZasZritten.263 By 1937Fthe year
before the enactment of the Federal Food, Drug, and Cosmetic Act of 1938Fthe
value of cosmetics industry production was about 132 million dollars.264
The tremendous growth of the industry was accompanied by a shift in the
acceptability of cosmetics use. Cosmetics use became more broadly acceptable
for women: for example, a 1915 article in McClure’s referred t, H,s.etiHs as
Daff,rding .uHC legitimate dailW H,.f,rt.3265 D\/[,.en fr,. aHr,ss tCe
country, from different social classes and racial-ethnic groups, enthusiastically
embraced cosmeticsFespecially makeupFin tCe earlW tZentietC HenturWS3
altC,ugC D\a[geS .arital statusS eH,n,.iH HlassS etCniH ,riginsS and residenHe
influenHed Z,.en’s relati,nsCi* t, tCe neZ .ass .arAet.3266
Cosmetics, particularly makeup, had a multitude of meanings.267 For
eXa.*leS Z,.en used H,s.etiHs Dt, *laW tCe ladW ,r tCe CussWS t, l,,A ,lder ,r
W,ungerS t, signifW H,..,n identities as 2#.eriHan’ and 2res*eHtableS’ ,r t,
in',Ae Hlass and etCniH distinHti,ns.3268 But despite these differences and
H,ntradiHti,nsS in tCe @8?Qs and @8>QsS D\.[aAeu* Zas a true eX*ressi,n ,f
fe.inine identitW3269 and bW tCe @8>QsS DCad beH,.e an aestCetiH eX*ressi,n
woven dee*lW int, Z,.en’s dailW life.3270
#t tCe sa.e ti.eS Z,rA*laHe a**earanHe re)uire.ents DbeHa.e inHreasinglW
regi.entedS3 b,tC re)uiring tCatZ,.enZear H,s.etiHs and regulatingZ,.en’s
cosmetics use.271 And the growth of the beauty industry opened up new
employment opportunities for women, e.g., as beauticians, product
demonstrators, and drugstore clerks.272 Entrepreneurs brought beauty culture and
261. VAIL, supra note 259, at 137.
262. See DUNN, supra note 1, at 37, 39, 42, 45-46 (S. 1944).
263. DUNN, supra note 1, at 1049 (Statement of the Honorable Henry A. Wallace, Secretary of
Agriculture).
264. See VAIL, supra note 259, at 137 (listing statistics from the reports of the United States Census
Bureau).
265. KAY, supra note 3, at 39.
266. PEISS, supra note 3, at 6, 168.
267. Id. at 6, 190.
268. Id. at 190.
269. Id. at 166. Conversely, D[c]osmetics were not readily reconciled with a heterosexual masculine
identity.3 Id.
270. Id. at 200.
271. See id. at 193.
272. Id. at 5.
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H,s.etiHs t, Hust,.ers and D.anW ,f tCe .,st suHHessful Zere i..igrantS
working-HlassS ,r blaHA Z,.en.3273
b. The Failures of the 1906 Pure Food and Drugs Act &
Consideration of Reform
Concerns about the safety of cosmetics and the limitations of the 1906 Act
accompanied the growth of the industry.274 These concerns reflect the gendered
state of cosmetics. In the 1930s, there were numerous reports of cosmetics
seriously injuring women, which the Pure Food and Drugs Act could not
prevent.275
Several books highlighted the dangers of cosmetics and the lack of
protections for consumers: for example, in 1933, Arthur Kallet and F.J. Schlink,
ZC, f,unded !,nsu.ers 1ni,n and !,nsu.ers’ 4esearHC InH.S *ublisCed tCe
influential book 100,000,000 Guinea Pigs.276 The book devotes a chapter to
D\d[anger \i[n \H[,s.etiHsS3 ZCiHC begins ZitC a state.ent ab,ut tCe danger,us
D*atC f,ll,Zed bW Z,.en of all times and of all countries in search of the beauty
*r,.ised bW .agiH and .Wsteri,us *,ti,ns.3277 TCe b,,A n,ted tCat D\t[Ce
*urHCaser ,f H,s.etiHs Cas n, *r,teHti,n ZCate'er3 and disHussed Z,.en
injured by cosmetics and cosmetic procedures.278 In 1934, Mary Catherine
6Cilli*sS als, ,f !,nsu.ers’ 4esearHCS *ublisCed Skin Deep: The Truth about
Beauty Aids&Safe and Harmful in res*,nse t, Dnu.er,us Z,.en readers3 ZC,
requested advice on cosmetics brands.279 In Skin Deep, Phillips was even more
explicit than Kallet and Schlink about who cosmetics consumers were: she stated
tCat DtCe fe.inine H,nsu.er Cas littleS if anW *r,teHti,n against danger,us
*,is,ns in tCe f,r. ,f H,s.etiHs.3280 Phillips also stated that for some cosmetics
Dlittle researHC Cas been d,ne ,f a scientific, disinterested nature that can be used
273. Id. at 5, 64-70 (discussing the entrepreneurial successes of Elizabeth Arden, Annie Turnbo
Malone, Helena Rubinstein, Madam C.J. Walker); see also Perry, supra note 100, at 580.
274. These were not the first concerns about or injuries caused by cosmetics. A number of cosmetics
in the mid-nineteenth century, for example, contained mercury, lead, and arsenic. See, e.g., PEISS, supra
note 3, at 21.
275. See, e.g., RUTH DEFOREST LAMB, AMERICAN CHAMBER OF HORRORS: THE TRUTH ABOUT
FOOD ANDDRUGS viii (1936); Pure Food and Drugs Act, supra note 229.
276. ARTHURKALLET&F.J. SCHLINK, 100,000,000 GUINEA PIGS: DANGERS IN EVERYDAY FOODS,
DRUGS, AND COSMETICS (1933).
277. Id. at 78.
278. Id. at 78, 82G84, 89, 94.
279. MARY CATHERINE PHILLIPS, SKIN DEEP: THE TRUTH ABOUT BEAUTY AIDSFSAFE AND
HARMFUL xi (1934). The 1940 Census identified Mary Catherine Phillips as white. See USA, BUREAU OF
THECENSUS, SIXTEENTHCENSUS OF THEUNITED STATES, 1940 (Washington, D.C.: National Archives &
Records Admin., 1940, T627, 4,643 rolls, accessed via Ancestry.com [database on-line]) (listing Mary C.
Schlink); see also THE HISTORICAL MARKER DATABASE, MARY CATHERINE PHILLIPS, https://
www.hmdb.org/marker.asp?marker=94693 [https://perma.cc/4ATL-JF75] (noting that Phillips married
Consumer’s Research founder Schlink).
280. Id. at 9.
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or relied on by consumers.3281 #nd in @8>;S 4utC deP,rest Ja.bS P_#’s first
Chief Education Officer, published American Chamber of Horrors, which
discussed the limits ,f tCe @8Q; #Ht and P_#’s laHA ,f autC,rity over
cosmetics.282 Like the authors of the other two books discussed above, she
provided examples of cosmetics that seriously injured women.283 The book was
based on an FDA-s*,ns,red eXCibit tCat Zas Ds, sC,HAing3 tCat a re*,rter
accompanying First Lady Eleanor Roosevelt to see the eXCibitS Ddubbed \it[ tCe
2#.eriHan !Ca.ber ,f N,rr,rs.’3284
These works also reflect the important role women played in bringing
attention to the problems of cosmetics and their regulation.285 In fact, Lamb
dedicated her book to the Dgallant gr,u* ,f Z,.en . . . holding the front-line
trenHCes in tCe H,nsu.ers’ Zar f,r *ure f,,dsS drugs and H,s.etiHs.3286 Women
and Z,.en’s ,rganiVati,ns *laWed a Hentral r,le in tCe *usC f,r tCe federal
regulation of cosmetics in the first part of the 20th century and the passage of the
1938 Federal Food, Drug, and Cosmetic Act. As Gwen Kay observes in her book,
Dying to Be Beautiful: The Fight for Safe CosmeticsS D\t[Ce leading *r,*,nents
for inclusion of cosmetics in a new law . . . Zere .,stlW Z,.en’s organizations
and H,nsu.er gr,u*s.3287
In @8>>S Senat,r !,*eland intr,duHed S.@8==S tCe D,riginal bill leading t,
tCe enaHt.ent ,f tCe \P_!#[.3288 P_#’s #nnual 4e*,rt tCat sa.e Wear n,ted
tCat federal laZZas DZC,llW ZitC,ut BurisdiHti,n ,'er H,s.etiHsS eXHe*t in tC,se
281. Id. at xi.
282. LAMB, supra note 275, at 15G39; FDA, Ruth deForest Lamb: FDA’s First Chief Educational
Officer, https://www.fda.gov/AboutFDA/History/VirtualHistory/HistoryExhibits/ucm341860.htm [https:
//perma.cc/KEA3-PCBU] [hereinafter FDA, First Chief Educational Officer]. The 1930 Census identified
DRuth Forest Lamb3 as white. USA, BUREAU OF THE CENSUS, FIFTEENTH CENSUS OF THE UNITED
STATES, 1930 (Washington, D.C.: National Archives & Records Admin. (1930) T626, 2,667 rolls,
accessed via Ancestry.com [database on-line]) [hereinafter FIFTEENTH CENSUS].
283. LAMB, supra note 275, at 15G39.
284. PEISS, supra note 3, at 197; LAMB, supra note 275, at 15G39; Vanessa Burrows et al., The
American Chamber of Horrors, FDA BLOG (June 29, 2018), https://web.archive.org/web/
20180925190340/https://blogs.fda.gov/fdavoice/index.php/2018/06/the-american-chamber-of-horrors/
(accessing June 29, 2018 Internet Archive). The FDA website notes that Lamb Dplayed a key role in
explaining to the public, to Congressmen, and particularly to their wives, the importance of updating the
1906 Pure Food and Drugs Act.3 FDA, First Chief Educational Officer, supra note 282. First Lady
Roosevelt Dappealed to America’s women to campaign for stronger protections for consumers.3 FDA,
100 Years of Protecting and Promoting Women’s Health, https://www.fda.gov/forconsumers/
byaudience/forwomen/ucm118458.htm#1933:_Protecting_the_Health_of_Women [https://perma.cc/29F
N-HCDT] (D1933: Protecting the Health of Women3).
285. See LAMB, supra note 275; PHILLIPS, supra note 279; KALLET& SCHLINK, supra note 276.
286. LAMB, supra note 275, at Dedication.
287. KAY, supra note 3, at 3; see, e.g., Foods, Drugs, and Cosmetics: Hearing Before a
Subcommittee of the Committee on Interstate and Foreign Commerce on H.R. 6906, H.R. 8805, H.R. 8941
and S. 5, Before the Subcomm. of the Comm. on Interstate and Foreign Commerce, 74th Cong. 1 (1935)
[hereinafter 1935 Hearing] (stating that the Director of the Bureau of Foods, Drugs, and Hotels of the
Kentucky Health Department in her testimony stated that she did not have to tell the committee Dthat the
woman consumer is very definitely interested in cosmetics3).
288. See DUNN, supra note 1, at 24, 29-30.
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rare instanHes ZCen tCe labeling bears .ediHinal Hlai.s.3289 S. 1944 would have
extended the Pure Food and Drugs Act of 1906 to prohibit the manufacture,
shipment, and sale of adulterated or misbranded cosmetics and the false
advertisement of cosmetics.290
In testi.,nW ,n tCe *r,*,sed legislati,nS P_#’s HCiefS /.O. !a.*bellS
referenHed DK,re.lu !rea.3 and DJasC JureS3291 two products that caused a
series of injuries to women and illustrated the limits of existing law.292 Koremlu
Zas a de*ilat,rW tCat used DtCalliu. aHetateS an ingredient H,..,nlW f,und in
rat *,is,nS t, destr,W and re.,'e Cair.3293 TCe H,s.etiHS ZCiHC DZas a**lied
mostly to women’s li*sS3 Haused Dl,ss ,f aXial ,r *ubiH Cair% baldness% te.*,rarW
or long-ter. *aralWsis% and ,*tiH ner'e da.age.3294 FDA cited Koremlu Cream
as an example of a product the federal government lacked authority over under
the 1906 Act, writing that the product was only removed from the market when
DtCe .anufaHturer Zas f,rHed int, banAru*tHW bW aHHu.ulati,n ,f da.age
suits.3295
DJasC JureS3 ZCiHC Zas used f,r dWing eWebr,Zs and eWelasCesS DH,ntained
paraphenylenediamine (PPD), an aniline dye that repeatedly achieved the rating
,f 2.,st danger,us’ in tCe list ,f Cair dWes.3296 It resulted in injuries ranging
fr,. Dte.*,rarW nauseaS disH,.f,rtS ,r 'isi,n *r,ble.s3 t, blindness and
289. Id. at 26 (reproducing portions of FDA’s 1933 Annual Report).
290. Id. at 30, 31, 33; S. 1944, 73rd Cong., § 2(c), 5, 6, 9.
291. DUNN, supra note 1, at 1122.
292. KAY, supra note 3, at 70. Koremlu is discussed in 100,000,000 Guinea Pigs, and both Koremlu
and Lash Lure are discussed in Skin Deep and American Chamber of Horrors. See KALLET & SCHLINK,
supra note 276; PHILLIPS, supra note 279; LAMB, supra note 275.
293. KAY, supra note 3, at 70. See, e.g., Hillick v. Edwards & Son, 143 Misc. 277 (N.Y. 1932)
(actions of three plaintiffs each alleging that she suffered injuries from the use of Koremlu Cream); Smith
v. Denholm & McKay Co., 192 N.E. 631 (Mass. 1934) (action by plaintiff alleging that she suffered
peripheral neuritis from thallium poisoning from Koremlu Cream); Greengard v. Odorono Co., 235 A.D.
806 (N.Y. 1932) (action by plaintiff alleging she developed severe skin poisoning from Odorono which
was advertised for use in Deliminating perspiration3). But see DUNN, supra note 1, at 1041 (statement of
American Medical Association representative) (noting Dcase of child swallowing Odorono,3 containing
Ddangerous lead acetate3)). In the United States, the use of thallium in rat poison has been banned Ddue to
its toxicity from accidental exposure.3 CDC NIOSH, Thallium: Systemic Agent, https://www.cdc.gov/
niosh/ershdb/emergencyresponsecard_29750026.html [https://perma.cc/R6VB-DY5H].
294. KAY, supra note 3, at 71.
295. DUNN, supra note 1, at 26 (reproducing portions of FDA’s 1933 Annual Report). In a 1934
Senate hearing, the FDA chief noted that Koremlu contained a rat poison Dfor which no antidote
has . . . been found3 and that it removes the hair not just from the site of application, but from the entirety
of the body. DUNN, supra note 1, at 1154.
296. KAY, supra note 3, at 71.
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death.297 Lash Lure was still on the market when the FDA chief first testified
about it.298
Koremlu and Lash Lure were not alone in injuring women. The legislative
Cist,rW ,f tCe P_!# indiHates tCat DeXtre.elW t,XiH substanHes3 suHC Das Hertain
coal-tar dWes and .etals liAe leadS arseniHS .erHurW and tCalliu.3 in Da nu.ber
of preparations . . . Haused seri,us i.*air.ent in tCe CealtC ,f users.3299
While the debate over the cosmetics provisions of legislation intended to
address shortcomings of the 1906 Act mentioned that men used cosmetics
Dt,,S3300 much of the focus was on women.301 Despite this, women’s direHt
participation in the legislative proceedings appears to have been relatively
limited and debate of the cosmetics provisions of bills reflected the
perspectivesFand biasesFof the male participants.
Senator Hattie W. Caraway, the sole woman Senator at the time, was present
for subcommittee hearings on the legislation.302 Women also testified on the
legislation before the subcommittee.303 ",tC Senat,r !araZaW’s .e.bersCi* ,n
the subcommittee and the testimony of women were of sufficient note that during
a _eHe.ber @8>> subH,..ittee CearingS DMrs. /illia. _iHA S*,rb,rg ,f 6,rt
!CesterS \IeZ ^,rA[3 re.arAed ,n tCe..304 SCe stated tCat sCe Zas DtCe first
woman . . . *er.itted t, a**ear3 at tCe Cearing and tCat Dall . . . .en3 Cad
testified before her that day and the day before.305 She also remarked that she
297. Id. at 72; see also Clyde E. Harner, Dermato-Opthalmitis Due to the Eyelash Dye Lash-Lure,
101 JAMA 1558-59 (1933) (reporting three cases of women injured by Lash Lure); Oliver P. Bourdon,
Severe Eye Symptoms Due to Dyeing the Eyelashes, 101 JAMA 1559 (1933) (reporting case of woman
injured by an eyelash dye, Larieuse); R. C. Jamieson, Eyelash Dye (Lash-Lure) Dermatitis with
Conjunctivitis, 110 JAMA 1560 (1933) (reporting case of woman injured by Lash-Lure); A. W. McCally
et al., Corneal Ulceration Following Use of Lash-Lure, 110 JAMA 1560 (1933) (reporting case of woman
injured by Lash-Lure); Sigmund S. Greenbaum,Dermatoconjunctivitis Due to Lash-Lure, An Eyelash and
Eyebrow Dye, 101 JAMA 363 (1933) (reporting case of woman injured by Lash-Lure); S. B. Forbes &
W. C. Blake, Fatality Resulting from the Use of Lash-Lure on the Eyebrow and Eyelashes, 103 JAMA
1441 (1934) (reporting fatality after using Lash-Lure). American Chamber of Horrors stated that there
were at least 17 cases of Lash Lure injuries reported in the Journal of the American Medical Association,
but there was no way to know how many women in total were so injured. LAMB, supra note 275, at 19.
298. DUNN, supra note 1, at 1154-55; see also LAMB, supra note 275, at 22.
299. DUNN, supra note 1, at 115-16; see also id. at 160; id. at 484; id. at 572 (quoting Congressman
Virgil Chapman as stating, DMany harmful and dangerous cosmetics have been sold to the public and used
by unsuspecting women so as to result in their permanent disfigurement and impairment of their health3);
id. at 256; Virgil Munday Chapman, HISTORY, ART & ARCHIVES, U.S. HOUSE OF REPRESENTATIVES,
http://history.house.gov/People/Listing/C/CHAPMAN,-Virgil-Munday-(C000317)/ [https://perma.cc/J8J
P-PW33]; see also DUNN, supra note 1, at 256.
300. See DUNN, supra note 1, at 156.
301. See, e.g., 1935 Hearing, supra note 287, at 165 (quoting Congressman Virgil Chapman as
stating that Dthe committee realizes that women use cosmetics externally, internally, and eternally3).
302. DUNN, supra note 1, at 150; at 96, 269-70, 597, 969; MANNING&BRUDNICK, supra note 254,
96-97. She later served as a conferee for the Senate. DUNN, supra note 1, at 597, 969. The 1930 Census
identified Senator Caraway as white. FIFTEENTH CENSUS, supra note 282.
303. See, e.g., Hearings Before a Subcommittee of the Committee on Commerce on S. 1944, 73rd
Cong. (1933) [hereinafter 1933 Hearings]; 1935 Hearing, supra note 287.
304. 1933 Hearings, supra note 303, at 339. The 1930 Census identified Mrs. William Sporborg as
white. FIFTEENTH CENSUS, supra note 282 (listing Constance Sporborg).
305. Id. at 339, 340.
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Zas Dglad t, see a Z,.an ,n tC\e[ Senat,rial !,..ittee ZC,se deHisi,ns and
recommendations will effect so many women who are users of drugs, cosmetics,
and f,,ds.3306
The Senate debate reflected the male Senat,rs’ attitudes t,Zards Z,.en.
_uring Senate debateS .ale Senat,rs referred t, a Dbeautiful girl3 ZC, Dl,st Cer
eWes3 and Cer 'isi,n after use ,f an eWelasC dWe.307 TCe Dbeautiful girlS3 ZC,
remains nameless through the debates, appears to have been a social worker who
was injured before a dinner to honor her civic activity by an eyelash dye that
H,ntained Da *,is,n.3308 The woman was likely Hazel Fay Brown (Musser),
whose injuries from Lash-Lure are described in detail (with before and after
photographs) in American Chamber of Horrors.309
During the debate, the woman is largely reduced to the subject of the male
Senat,r’s 'ieZing.310 Senat,r !,*eland a**eared t, B,Ae ab,ut sub.itting DtCe
*C,t,gra*C ,f a beautiful W,ung Z,.an3 t, Senat,r Ma.es Na.ilt,n JeZisS
*r,.,ting ,bBeHti,ns ab,ut ,tCer Senat,rs eX*erienHing Den'W3 and DtCe
sus*ensi,n ,f *r,*er senat,rial aHti'itiesS3 as Zell as laugCter.311 Senator
!,*eland res*,nded bW stating tCat Ce Z,uld Dgi'e \tCe *C,t,gra*C[ t, tCe
Senate . . . so that there may be no feeling ,f disHri.inati,n.3312 Senator Lewis,
in an a**arent referenHe t, tCe *C,t,gra*CS D,bBeHt\ed[ t, tCe eXCibitsZCiHC Ca'e
Haused tr,uble.3313 And, Senator Matthew M. Neely expressed concern about
Senat,r !,*eland Dabs,rbing tCe entire attenti,n ,f tCe Senate in the
*C,t,gra*Cs ,f tCe beautiful girl.3314
Discussion of the cosmetics provisions of the proposed legislation was
punctuated by laughter: Senator Copeland after remarking on the manufacture,
sale, and use of cosmetics, prompted laughter when he joked about Senator
JeZis Ca'ing Dn, d,ubt . . . been a *r,f,und student in tCe fields in',l'ed.3315
There was als, laugCter after Senat,r IeelW stated tCat li*stiHA Dis n,t safe f,r
.enS3 and again after Senat,r !,*eland asAedZCetCer Senat,rIeelW Z,uld liAe
t, DtestifW ,n tCe subBeHt at anW great lengtC.3316
306. Id. at 344.
307. DUNN, supra note 1, at 156-57, 279.
308. Id. at 156, 279.
309. LAMB, supra note 275, at 15-18; KAY, supra note 3. The 1930 Census identified Hazel Fay
Musser as white. FIFTEENTH CENSUS, supra note 282.
310. FDA’s chief, W.G. Campbell appears to have shown a photograph of the injured woman during
a 1934 Senate hearing. See DUNN, supra note 1, at 1154-55.
311. Id. at 156; see also U.S. SENATE, SENATORS OF THE UNITED STATES, 1789-PRESENT,
https://www.senate.gov/artandhistory/history/resources/pdf/chronlist.pdf [https://perma.cc/ZG2M-6KW
6] [hereinafter SENATORS OF THEUNITED STATES] (listing Senators chronologically).
312. Id.
313. DUNN, supra note 1, at 156.
314. Id.; SENATORS OF THEUNITED STATES, supra note 312, at 56.
315. DUNN, supra note 1, at 156.
316. Id.
2018] Gender, Race & the Inadequate Regulation of Cosmetics 317
TCe debate als, refleHted tCe .ale Senat,rs’ Budg.ents ab,ut Z,.en’s use
,f H,s.etiHs: f,r eXa.*leS Senat,r IeelW re.arAed tCat Ce’d be D'erW .uHC
.,re entCusiastiH ab,ut tCe bill if it3 DH,ntain\ed[ an inCibition against the
eXHessi'e use ,f tCe ab,.inable li*stiHA.3317 And Senator Connally remarked
tCat D\i[t see.s . . . the more solemn [women] are, the less cosmetics they
use.3318 In contrast, Senator Copeland, who led the push for new legislation,
remarked that the woman who was blinded after using the eyelash dye was
D*re*aring CerselfS as sCe *r,*erlW sC,uld f,r an ,HHasi,n s, i.*,rtant t, Cer.3319
#nd tCat Ce Zas Dglad t, saW tCere3 tCat tCe bill did n,t *r,Cibit tCe use ,f
lipstick.320 Senator Copeland remarked tCat Ce 'ieZed Dit as tCe s,le.n dutW ,f
e'erW Z,.an t, be as beautiful as sCe Han be3 and tCat Ce did Dn,t bla.e anW
woman for using cosmetics if they tend in the direction of making her more
attraHti'e.3321 In explaining what he meant by solemn duty, he later statedS DI
mean, of course, it is my solemn duty to help them to be as beautiful as they can
be.3322
In the course of the legislative debate, Senator Copeland referenced the Dfair
Z,.an3 beH,.ing fairer as a result ,f H,s.etiH use.323 Given racialized notions
of beauty,324 this may have had racial undertones. Senator Copeland went on to
state tCat tCe Senate’s Dres*eHt f,r \tCe fair Z,.an[ is suHC tCat \tCeW[ desire tCat
ZCate'er sCe uses .aW be safe t, use.3325 Who the law was intended to protect
was at times described in limited terms. For example, Senator Copeland
re.arAedS DI Zant all Z,.enS in whom I have an interest, to be guarded and
*r,teHted against tCe use ,f tCings ZCiHC .aW be da.aging.3326 Copeland also
a**ealed t, Cis fell,Z.ale senat,rsS stating tCat D\e['erW Senat,r Ca'ing in.ind
the welfare of his wife, his children, his grandchildren, and his great-children if
there be such, is interested in having the measure enacted into law because of
what it will doFpromote their welfare, maintain their health, and extend their
li'es.3327
Devaluation of Cosmetics & Cosmetics Law & Regulation
Food is life-sustaining and everyone must eat. Drugs may treat serious
illness and can be lifesaving. In contrast to those traditional product categories
317. Id.
318. Id. at 278.
319. Id. at 156.
320. Id.
321. Id. at 278.
322. Id. at 279.
323. Id. at 694.
324. See KAY, supra note 3; PEISS, supra note 3.
325. DUNN, supra note 1, at 694.
326. Id. at 278 (emphasis added).
327. Id. at 185 (emphasis added). But see id. at 155 (quoting Senator Copeland as stating that the
Dbill is intended to safeguard the men and women, the boys and girls, and the babies of this country3).
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in the FDCA, cosmetics are often viewed as frivolous or trivial.328 The
trivialization of cosmetics may be reinforced by the very meaning of the word
DH,s.etiHS3 as ,ne H,..,n definiti,n is Dsu*erfiHial.3329
While cosmetics have different meanings for different womenFand these
meanings are shaped by factors including race and socio-economic statusF
cosmetics are closely associated with femininity. In particular, cosmetics are
ass,Hiated ZitC a Ddee*lW-ingrained American cultural definition of femininity
den,ted as a *artiHular Aind ,f H,..erHialiVed fe.inine beautW.3330 Indeed,
cosmetics use has been shown to significantly impact impressions of
femininity.331
At the same time that cosmetics are closely associated with femininity, traits
and qualities associated with women or femininity have been devalued.332 For
eXa.*leS MarW #nne !. !ase Cas n,ted DtCe H,ntinuing de'aluati,nS in life and
in laZS ,f )ualities dee.ed fe.inine.3333 And as Deborah Zalesne has observed,
in Jespersen v. Harrah’s Operating Co., Inc.Fa case that unsuccessfully
challenged the firing of a female bartender for failing to comply with her
e.*l,Wer’s a**earanHe standardsS ZCiHC re)uired fe.ale e.*l,Wees t, Zear
makeupFDthe court failed . . . to consider the fact that the makeup, hair, and
dress requirements are deeply rooted in traditional notions of how men and
women should look and are based on stereotypes that deride feminine traits and
.arginaliVe indi'iduals ZC, *,ssess suHC traits.3334
328. See, e.g., POUCHER’S PERFUMES, COSMETICS AND SOAPS (Hilda Butler ed., 10th ed. 2000);
Dellinger & Williams, supra note 93, at 153; WOLF, supra note 4, at 9.
329. See Cosmetic, OXFORD ENGLISH DICTIONARY ONLINE (Oxford University Press) (Aug. 14,
2018).
330. See Steve Craig, Feminism, Femininity, and the “Beauty”Dilemma: How Advertising Co-opted
the Women’s Movement, THE FEMINIST EZINE http://www.feministezine.com/feminist/fashion/The-
Beauty-Dilemma.html [https://perma.cc/QWA4-D4AQ]; see alsoKathy Peiss,Making Up, Making Over:
Cosmetics, Consumer Culture, and Women’s Identity, in THE SEX OF THINGS: GENDER&CONSUMPTION
INHISTORICAL PERSPECTIVE 311, 330 (Victoria de Grazia & Ellen Furlough eds., 1996) (stating that D[i]n
the period from 1900 to 1930, making up became one of the tangible ways women in their everyday lives
confirmed their identities as women3).
331. See, e.g., Richard Russell, A Sex Difference in Facial Contrast and Its Exaggeration by
Cosmetics, 28 PERCEPTION 1211, 1217 (2009) (suggesting that Dan important function of cosmetics may
be to increase the apparent femininity, and hence attractiveness, of the female face by increasing facial
contrast3); Jane E. Workman & Kim K.P. Johnson, The Role of Cosmetics in Impression Formation, 10
CLOTHING & TEXTILES RES. J. 63 (1991) (stating that D[r]esults support the use of cosmetics as a cue in
forming impressions of another’s . . . femininity3); Cathryn L. Cox & William H. Glock, Resume
Evaluations and Cosmetics Use: When More Is Not Better, 14 SEX ROLES 51, 51, 56 (1986) (noting that
D[c]osmetics use has been traditionally used by women to control their physical appearance3 and finding
Dthat cosmetics tend to enhance the perceived attractiveness and femininity of women3).
332. See, e.g., Case, supra, note 35; Maxine Eichner, On Postmodern Feminist Legal Theory, 36
HARV. C.R.-C.L. L. REV. 1, 72 (2001).
333. Case, supra note 332, at 3.
334. Deborah Zalesne, Lessons from Equal Opportunity Harasser Doctrine: Challenging Sex-
Specific Appearance and Dress Codes, 14 DUKE J. GENDER L. & POL’Y 535, 554 (2007); see also
Jespersen v. Harrah’s Operating Co., Inc., 444 F.3d 1104 (9th Cir. 2006).
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FDA is not immune to sociopolitical influences.335 Thus, the association
with women and femininity may have contributed to cosmetics law and
regulati,n being de*ri,ritiVed. 7tCers Ca'e argued tCat DP_# Cas been an
inade)uate *r,teHt,r ,f Z,.en’s CealtC3 and tCat DP_# inaHti,n \Cas[ directly
da.aged tCe CealtC ,f large nu.bers ,f Z,.en ,n .,re tCan ,ne ,HHasi,n.3336
P_#’s guidelinesFConsiderations for the Clinical Evaluation of DrugsFfor
.anW Wears DlargelW excluded women of childbearing potential from clinical
trialsS3 a *,siti,n tCat .anW 'ieZed as DrefleHt\ing[ gender stere,tW*ing .,re
tCan H,nHerns ab,ut g,,d sHienHe.3337
Gender gaps in clinical research may also impact the studyFand
regulationFof cosmetics safety.338 MediHine DgenerallW Cas *aid .,re attenti,n
to the risks and benefits of new drugs with a male model in mind, rather than a
fe.ale3339 and DAn,Zledge H,nHerning tCe effeHts ,f 'ari,us treat.ents ,n
Z,.en and tCeir uni)ue needs re.ains s*arse and underde'el,*ed.3340 Current
knowledge of the effects of cosmetics, a highly gendered produHtS ,n Z,.en’s
health, is similarly underdeveloped. For example, one epidemiologist at the
Nar'ard T.N.!Can SHC,,l ,f 6ubliH NealtC stated tCat D\f[,r deHadesZe’'e been
studWingZCat’s in tCe air tCat W,u breatCe and tCeZater W,u drinA. "ut W,uZaAe
up in the morning . . . and you may use a shampoo or a conditioner, and a
335. See Mara Sanders, Sex, Drugs, and Advisory Committees: An Analysis of Pharmaceutical
Industry Manipulation of FDA Vulnerability to Sociopolitical Influences on Matters of Women’s Health,
48 COLUM. HUM. RTS. L. REV. 149, 150 (2017) (arguing that FDA Ddisplays a number of biases that
distort scientific analysis, from normative judgments about women’s sexuality to a patronizing sense that
women require heightened protection against the risks posed by otherwise effective drugs3).
336. Thomas Koenig & Michael Rustad, His and Her Tort Reform: Gender Injustice in Disguise, 70
WASH. L. REV. 1, 51 (1995); see also Pub. Citizen Health Research Grp. v. Comm’r, Food & Drug
Admin., 724 F. Supp. 1013, 1021 (D.D.C. 1989) (holding that Da more than seven year delay in issuing a
regulation impacting on women’s health is certainly an unreasonable delay3); Amanda L. Allen, A Plan
C for Plan B: A Feminist Legal Response to the Ways in Which Behind-the-Counter Emergency
Contraception Fails Women, 11 N.Y. CITY L. REV. 401, 411 (2008) (arguing that D[a]t the very least, the
ways in which the FDA decision [regarding Plan B, an emergency contraceptive] privileged antiquated
views about women’s and girls’ sexuality along with the ideological agenda of a conservative presidential
administration over science, medicine, and women’s health offers support for the feminist critique of the
law as an inherently patriarchal institution3); Vicki Lawrence MacDougall, Medical Gender Bias and
Managed Care, 27 OKLA. CITY U. L. REV. 781, 786 (2002) (Drais[ing] the haunting question whether
managed care has the built-in propensity to perpetuateFif not sanction and encourageFmedical gender
bias to the detriment of the health of women enrolled in managed care plans3); Rebecca
Weisman, Reforms in Medical Device Regulation: An Examination of the Silicone Gel Breast Implant
Debacle, 23 GOLDEN GATE U. L. REV. 973, 982 (1993) (discussing silicone gel breast implants,
diethylstilbestrol (DES), and the Dalkon Shield and arguing that Dfailed to act responsibly when dealing
with products affecting women’s health and safety3).
337. Karen H. Rothenberg,GenderMatters: Implications for Clinical Research andWomen’s Health
Care, 32 HOUS. L. REV. 1201, 1239 (1996); see also Christina Cole, Women and the FDA: Remedying
the Past and Preserving the Future, 7 HOUS. J. HEALTH L. & POL’Y 127, 129 (2006).
338. See, e.g., Rothenberg, supra note 337, at 1208.
339. Ruth B. Merkatz, Women in Clinical Trials: An Introduction, 48 FOOD& DRUG L.J. 161, 162
(1993).
340. Rothenberg, supra note 337, at 1203.
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toothpaste, and cosmetics, and they all contain many different chemicals. And
Ze *rettW .uHC ne'er tC,ugCt ab,ut tCe..3341
B. Reform of Cosmetics Law & Regulation Must Confront Tensions Resulting
from the Debate Among Feminists Regarding the Meaning of Cosmetics &
Economic Opportunities in the Cosmetics Industry
The debate among self-described feminists regarding the meaning of
cosmetics and differences among women with respect to cosmetics may
complicate reform efforts. As discussed earlier, the use of, exposure to, and
meaning of cosmetics may differ as a result of the intersections between gender,
race, and class.342 In addition, the economic and entrepreneurial opportunities
that cosmetics may provide may create tensions that may further complicate
efforts to reform cosmetics law and regulation.
The Debate Among Self-Described Feminists
There is substantial debate among feminists over the meaning of cosmetics
and the cosmetics industry. This debate is part of a larger debate about beauty
and appearance.343 In her essay, Appearance as a Feminist Issue, Rhode
desHribes an DinHreasinglW frag.ented3 fe.inist .,'e.ent in ZCiHC Ddifferent
subHultures Ca'e differed sCar*lW ,n .atters ,f a**earanHe.3344
Some feminists are concerned about the costs of appearance norms,
inHluding finanHial H,stsS CealtC risAsS disHri.inati,nS DtCe de'aluati,n and
seXualiVati,n ,f Z,.enS3 and tCe exacerbation of economic, racial, and gender
inequalities.345 P,r eXa.*leS Ia,.i /,lf argues tCat i.ages ,f fe.ale beautW3
are used Das a *,litiHal Zea*,n against Z,.en’s ad'anHe.ent3 and tCat
cosmetics and the cosmetics industrW H,ntribute t, tCis DbeautW .WtCS3
pressuring women to adhere to unrealistic beauty standards and hence
constraining them.346 7tCer fe.inists Ca'e f,Hused ,n D\a[**earanHe \a[s an
341. Rebecca Kessler,More than Cosmetic Changes: Taking Stock of Personal Care Product Safety,
123 ENVIRO. HEALTH. PERSP. A120 (2015), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421754/
[https://perma.cc/Z2PH-WJQT].
342. See supra Sections II.A & B. They may also differ based on other characteristics including
sexual orientation, ethnicity, socio-economic status, and age.
343. See Deborah L. Rhode, Appearance as a Feminist Issue, 69 SMU L. REV. 697, 697 (2016)
(stating that Das the feminist movement has grown increasingly fragmented, different subcultures have
differed sharply on matters of appearance3 and that D[w]hen it comes to appearance, what women want is
not always the same or always compatible3); see also SUSANBROWNMILLER, FEMININITY 157-61 (1984)
(discussing the feminism and the tensions over makeup).
344. Rhode, supra note 343, at 699; see also Craig, supra note 330.
345. Id. at 699-704.
346. NAOMIWOLF, THE BEAUTYMYTH: HOW IMAGES OF BEAUTYAREUSEDAGAINSTWOMEN 9-
10, 107, 115-18 (1992).
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opportunity for self-expression and self-deter.inati,nS3 albeitZitC li.its.347 For
example, Jennifer Baumgardner and #.W 4iHCards Ca'e argued tCat D\u[sing
.aAeu* isn’t a sign ,f ,ur sZaW t, tCe .arAet*laHe and tCe .ale gaVe% it Han be
sexy, campy, ironic, or simply decorating ourselves without the loaded
issues.3348
However, regardless of how one views cosmetics use, the current state of
cosmetics law and regulation is concerning because many women use or are
exposed to cosmetics. If cosmetics use generally is oppressive, then the current
state of cosmetics law and regulation reinforces this because it disproportionally
*uts Z,.en’s CealtC at risA. If H,s.etiHs use is liberatingS tCen tCe Hurrent state
of cosmetics law and regulation is troubling because cosmetics use is not
liberating if it comes with unknown and, thus, unaccepted risks.
Cosmetics, Entrepreneurship & Economic Opportunity
/,.en’s di'ergent interests .aW als, Cinder tCe de'el,*.ent ,f H,s.etiHs
law and regulation. As discussed in Section II.B, cosmetics use and exposure
may have negative health effects. But cosmetics are also big business,349 and it
is important to recognize the economic opportunities that the cosmetics industry
has provided and continues to provide women, including women who are
.e.bers ,f ,tCer eXHluded gr,u*s. /,.en’s eH,n,.iH interests and
considerations will likely impact any potential reforms.
There is a long history of the cosmetics industry providing economic
,**,rtunities f,r di'erse Z,.en. P,r eXa.*leS 6eiss Zrites tCat ZCile DbeautW
culture mainly offered women low-wage work, it became one of a handful of
occupations . . . t, sustain fe.ale entre*reneursCi* and ,ZnersCi*3 and
D\Z[,.en . . . became inventors, manufacturers, and distributors of beauty
*r,duHts.3350
The women entrepreneurs came from different classes (although many were
poor), were of different races, and were both immigrants and native-born.351 For
example, Annie Turnbo Malone and Sarah Breedlove (known as Madam C.J.
Walker) were two black women entrepreneurs who built thriving businesses
selling hair care products,352 an industrW tCat Cas Dl,ng been ,ne ,f tCe feZ sites
,f suHHess f,r blaHA Z,.en entre*reneurs.3353 Florence Nightingale Graham,
347. Rhode, supra note 343, at 705G07.
348. Jennifer Baumgardner & Amy Richards, Feminism and Femininity: Or How We Learned to
Stop Worrying and Love the Thong, in ALL ABOUT THE GIRL: CULTURE, POWER, AND IDENTITY 59, 60
(Anita Harris ed., 2004).
349. See supra note 2 and accompanying text.
350. PEISS, supra note 3, 62-63.
351. Id. at 63G64, 96.
352. Id. at 67G70.
353. Monica C. Bell, The Braiding Cases, Cultural Deference, and the Inadequate Protection of
Black Women Consumers, 19 YALE J.L. & FEMINISM 125, 128, 133 (2007) (arguing that Dstate legislators
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who grew up in poverty in Canada, established Elizabeth Arden.354 And Helena
4ubinsteinS ZC, Ha.e fr,. Da.iddling MeZisC fa.ilW3 and.,'ed t, IeZ^,rA
from Europe after World War I started, began a cosmetics company bearing her
name.355 #ll f,ur ,f tCese Z,.en built Dbusiness e.*ires.3356 Although there is
some debate over whether Malone or Breedlove was the first black female
millionaire in the United States, both women were among the first.357
Beauty work, including that involving the use of cosmetics, is still often
done by women, and women comprise the majority of workers in many jobs that
involve such work.358 According to the chief scientist of the Personal Care
6r,duHts !,unHilS D\Z[omen and people of color account for nearly 74% of all
employment in the personal care products sector and 61.2% of management
*,siti,ns.3359 As a result, many women have an economic interest in cosmetics,
which may be impacted by changes in cosmetics law and regulation. For
example, in 2012, Deborah May testified at a Congressional hearing about the
economic contributions that the handcrafted soap and cosmetic industry
makes.360 SCe stated tCat tCe DindustrW is ,'er ?QQSQQQ s.all businesses Cand
producing small batHCes ,f s,a*s and H,s.etiHsS3 ,f ZCiHC 8<- Dare Z,.en-
,Zned3 and urged eXe.*ti,ns f,r s.all businesses fr,. if P_#Zere t, be gi'en
new authority over cosmetics.361 Accordingly, any reform efforts may confront
opposition from those with divergent interests.
should exempt braiders from cosmetology licensing requirements and authorize state administrators to
promulgate substantive regulations that are reasonably related to braiding and natural styling3); see also
Perry, supra note 100, at 581.
354. PEISS, supra note 3, 64-66.
355. Id. at 66-67
356. Id. at 70.
357. See, e.g.S #’Jelia "undlesS Madam C.J. Walker, ENCYCLOPÆDIA BRITANNICA, https://
www.britannica.com/biography/Madam-C-J-Walker [https://perma.cc/TJ38-3QY6]; Henry Louis Gates,
Jr., Madam Walker, the First Black American Woman to Be a Self-Made Millionaire, PBS.ORG,
https://www.pbs.org/wnet/african-americans-many-rivers-to-cross/history/100-amazing-facts/madam-
walker-the-first-black-american-woman-to-be-a-self-made-millionaire/ [https://perma.cc/9APK-ZEXV];
Detetria Irwin, [Unsung Sheroes] Beauty Pioneer Annie Turnbo Malone Opens Doors for Others,
EBONY.COM (Mar. 23, 2006), https://www.ebony.com/black-history/annie-turnbo-malone-ebonywhm/
[https://perma.cc/BT8Z-TZFL].
358. KAY, supra note 3; PEISS, supra note 3; see also BLS, DETAILED OCCUPATION, supra note 6
and accompanying text (discussing occupational data); BLS, DETAILED INDUSTRY, supra note 96 and
accompanying text (same).
359. Exploring Current Practices in Cosmetic Development and Safety Before the S. Comm. on
Health, Education, Labor and Pensions, 114th Cong. 3, 3 (2016) (Statement of Beth Lange Jonas, Chief
Scientist, Personal Care Products Counsel), https://www.help.senate.gov/imo/media/doc/Jonas3.pdf
[https://perma.cc/VH7K-8K6P].
360. Hearing: Examining the Current State of Cosmetics Before the H. Comm. on Energy &
Commerce, Subcomm. On Health, 112th Cong. 140, at 2 (2012) (Statement of Deborah May, President
and CEO, Wholesale Supplies Plus, Inc.), https://archives-energycommerce.house.gov/sites/republicans.
energycommerce.house.gov/files/Hearings/Health/20120327/HHRG-112-IF14-WState-MayD--2012032
7.pdf [https://perma.cc/G2SH-5CZN].
361. Id. at 4. She also stated that she supported several principles related to cosmetic regulation. Id.
at 4G5.
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IV. REFORMING COSMETICS LAW&REGULATION
Finally, this Article considers how asking the woman question and the
excluded group question could inform reform efforts.362 It is mindful of the fact
that the method that it employs does not lead to a particular end. It does, however,
reveal the gendered roots of cosmetics law and regulation, and highlight the need
to further investigate how cosmetics and the current state of cosmetics law and
regulation impact women, including members of excluded groups. It is not
enough to simply claim that cosmetics are the safest product category that FDA
regulates, as the current state of cosmetics law and regulation hinders the ability
to meaningfully assess the safety of cosmetics. This Article suggests several
changes to begin to reform cosmetics law and regulation to better account for
Z,.en’s eX*erienHes, safety, and needs.
A number of scholars and other commentators have proposed or supported
reforms to cosmetics law and regulations.363 In addition, the General Accounting
Office has studied and issued recommendations on cosmetics law and
regulation,364 and members of Congress have introduced bills to strengthen
cosmetics law.365 While many of these proposals and bills suggest fairly broad
cosmetics reforms, the reforms that this Article argues for are more limited in
scope.366 This is not to say that additional reforms are not neededFthey very
well may be. As an initial matter, however, this Article argues for reforms that
facilitate the collection of information to more accurately assess the safety of
cosmetics and the risks that they may pose to human health, including that of
diverse women. The reforms that this Article suggests would also begin to
narrow the gap between the regulation of cosmeticsFa highly gendered
productFand that of the other major product categories, which lack the same
gendered history and associations.
First, Congress and FDA should require that establishments involved in the
production and distribution of cosmetics intended for use in the United States
register with the FDA, just as food, drug, device, biologics, and tobacco product
362. See Bartlett, supra note 16, at 837.
363. See, e.g., De Paz, supra note 117; Mason, supra note 158; Julie Mueller, Pulling Our Hair Out
and Glossing over the Problem: A Call to Strengthen the FDA’s Power to Regulate Cosmetics Through
an Amendment to the Federal Food, Drug, and Cosmetic Act, 79 U. PITT. L. REV. 317 (2017); Shah &
Taylor, supra note 99; Brittany Stepp, You Don’t Know What’s in Your Shampoo, and Neither Does the
FDA: A Call for Change, 10 DREXEL L. REV. 277 (2017); Watnick, supra note 117; Johnson, supra note
116, at 120.
364. GAO, HRD-78-139, supra note 9; see also STATEMENT OF GREGORY J. AHART, supra note 9;
GAO/HRD-90-58, supra note 9.
365. See, e.g., Cosmetic Modernization Amendments of 2017, H.R. 575, 115th Cong. (2017); FDA
Cosmetic Safety and Modernization Act, S. 2003, 115th Cong. (2017); Personal Care Products Safety
Act, S. 1113, 115th Cong. (2017).
366. There is overlap, however, between the reforms that this Article argues are needed and those
proposed by others. See, e.g., Cosmetic Modernization Amendments of 2017, H.R. 575, 115th Cong.
(2017); FDA Cosmetic Safety and Modernization Act, S. 2003, 115th Cong. (2017); Watnick, supra note
117, at 637G49 (discussing federal legislative proposals); Mueller, supra note 363.
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establishments do.367 Registration requirements help to facilitate post-market
enforcement activities.368 Without mandatory registration, FDA may not even
know that a facility is producing cosmetics.
Second, Congress and FDA should require that cosmetics establishments
also be required to provide FDA with a listing of ingredients used in cosmetic
products intended for use in the United States. As noted above, filing ingredient
statements for each cosmetic product is currently voluntary.369 In response to a
comment requesting that FDA make the program mandatory, FDA stated that it
DCas n, statut,rW autC,ritW t, re)uire .andat,rW H,s.etiH *r,duHt re*,rting.3370
Together, establishment registration and product listing requirements would
provide FDA with informati,n ab,ut DtCe l,Hati,nsS business trade na.esS and
types of activity (manufacturing or packaging) of cosmetic product
establisC.entsS3 and Cel* faHilitate tCe distributi,n ,f regulat,rW inf,r.ati,n and
the conduct of inspections.371
Third, Congress and FDA should require that cosmetics manufacturers and
distributors report certain adverse events to the agency. As noted above, there is
n, re)uire.ent tCat suHC e'ents be re*,rtedS ZCiHC Ca.*ers P_#’s abilitW t,
monitor the safety of cosmetics. The required adverse event reporting should
include demographic information, including sex, race, and ethnicity, for the
person who experienced the event.
P,urtCS !,ngress sC,uld eXtend P_#’s autC,ritW ,'er H,s.etiHs t, all,Z tCe
agency to inspect records under certain circumstances.372 As noted above, under
tCe P_!#S P_#’s general ins*eHti,n autC,ritW ZitC res*eHt t, H,s.etiHs is
limited to certain establishments and vehicles.373
PiftCS !,ngress and P_# sC,uld H,lleHt and *ublisC data ,n P_#’s
regulatory activities and budget for cosmetics in an easily accessible format. As
noted above, such information is not currently readily available, and without this
367. FDCA §§ 415, 510, 901, 905; 21 C.F.R. §§ 207, 607, 807 (2018); FDA, BIOLOGICS
ESTABLISHMENT REGISTRATION, https://www.fda.gov/BiologicsBloodVaccines/GuidanceCompliance
RegulatoryInformation/EstablishmentRegistration/default.htm [https://perma.cc/RJ2N-V2U5] (2018);
FDA, REGISTRATION AND PRODUCT LISTING FOR OWNERS AND OPERATORS OF DOMESTIC TOBACCO
PRODUCT ESTABLISHMENTS (Dec. 2017), https://www.fda.gov/TobaccoProducts/Labeling/RulesReg
ulationsGuidance/ucm189539.htm [https://perma.cc/8M9T-36YE].
368. See, e.g., Requirements for Foreign and Domestic Establishment Registration and Listing for
Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal
Drugs, 81 Fed. Reg. 60,170, 60170 (Aug. 31, 2016); see also Registration of Food Facilities Under the
Public Health Security and Bioterrorism Preparedness and Response Act of 2002, 68 Fed. Reg. 58,894
(Oct. 10, 2003); Amendments to Registration of Food Facilities, 81 Fed. Reg. 45,912 (July 14, 2016).
369. See Agency Information Collection Activities; Submission for Office of Management and
Budget Review; Comment Request; Voluntary Cosmetic Registration Program, 73 Fed. Reg. 76,360 (Dec.
16, 2008).
370. 73 Fed. Reg. 76,361.
371. See Reducing Regulation and Controlling Regulatory Costs, 69 Fed. Reg. 9,339, 9,339 (Feb. 3,
2017).
372. See FDCA § 704, 21 U.S.C. § 374 (2012).
373. FDCA § 704(a), 21 U.S.C. § 374; see also FDCA §§ 801-802, 21 U.S.C. §§ 381-382; 21 C.F.R.
§ 1.101 (2018) (recordkeeping requirements for certain cosmetics exports).
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inf,r.ati,n it is diffiHult t, fullW assess tCe ade)uaHW ,f P_#’s H,s.etiHs
regulation.374
Finally, Congress and FDA should encourage more research into the
*,tential CaVards tCat H,s.etiHs .aW *,se t, Z,.en’s CealtCS inHluding t,
members of other excluded groups, such as racial and ethnic minorities.
The proposals in this Section are not intended to serve as a comprehensive
fix, but rather to serve as first steps designed to provide the information needed
to more fully assess the current state of cosmetics law and regulation and the
safety of cosmetics.
CONCLUSION
Examining cosmetics law and regulation through a feminist lens
demonstrates how the shortcomings of current regulatory approach
dis*r,*,rti,natelW Be,*ardiVe Z,.en’s CealtC. !,s.etiHs are Hl,selW ass,Hiated
with cultural constructs of femininity and womanhood, and are a highly gendered
product and industry. While women use more cosmetics than men and are the
majority of workers in the cosmetics industry,375 cosmetics law and regulation
Ca'e largelW negleHtedZ,.en’s di'erse eX*erienHes and needs. TCese ,.issi,ns
impact women differently and may vary as a result of many factors, including
race and socio-economic status.376 Recognizing the failure of current cosmetics
law and regulation for women is a precursor to remedying these injustices.377
The impact of these shortcomings, however, is not limited to women who use
cosmetics, either personally or at work. Men and children also use cosmetics,
and everyone, regardless of whether they use cosmetics or not, may be exposed
to cosmetics. Thus, cosmetics law and regulation should be strengthened in order
to more accurately assess the risks that cosmetics may pose to human health.
374. See supra Section II.C.2.c.
375. See supra Section II.A.
376. See Rothenberg, supra note 337, at 1207.
377. See David Stowman, Getting to Know Ourselves, BENCH&B.MINN. 5 (Feb. 2005).
